Henry Yamamura

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Anatomy

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Yamamoto Takashi; Nair Padma; Ma Shou-wu; Davis Peg; Yamamura Henry I; Vanderah Todd W; Porreca Frank; Lai Josephine; Hruby Victor J
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety.
Tumati Suneeta; Yamamura Henry I; Vanderah Todd W; Roeske William R; Varga Eva V
Sustained morphine treatment augments capsaicin-evoked calcitonin gene-related peptide release from primary sensory neurons in a protein kinase A- and Raf-1-dependent manner.
Tumati Suneeta; Yamamura Henry I; St John Paul A; Vanderah Todd W; Roeske William R; Varga Eva V
Sustained cannabinoid agonist treatment augments CGRP release in a PKA-dependent manner.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Henry Yamamura (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Yamamoto Takashi; Nair Padma; Ma Shou-wu; Davis Peg; Yamamura Henry I; Vanderah Todd W; Porreca Frank; Lai Josephine; Hruby Victor J
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety.
Bioorganic & medicinal chemistry 2009;17(20):7337-43.
2009: Tumati Suneeta; Yamamura Henry I; Vanderah Todd W; Roeske William R; Varga Eva V
Sustained morphine treatment augments capsaicin-evoked calcitonin gene-related peptide release from primary sensory neurons in a protein kinase A- and Raf-1-dependent manner.
The Journal of pharmacology and experimental therapeutics 2009;330(3):810-7.
2009: Tumati Suneeta; Yamamura Henry I; St John Paul A; Vanderah Todd W; Roeske William R; Varga Eva V
Sustained cannabinoid agonist treatment augments CGRP release in a PKA-dependent manner.
Neuroreport 2009;20(8):815-9.
2009: Nair Padma; Yamamoto Takashi; Kulkarni Vinod; Moye Sharif; Navratilova Edita; Davis Peg; Largent Tally; Ma Shou-Wu; Yamamura Henry I; Vanderah Todd; Lai Josephine; Porreca Frank; Hruby Victor J
Novel bifunctional peptides as opioid agonists and NK-1 antagonists.
Advances in experimental medicine and biology 2009;611():537-8.
2008: Tumati Suneeta; Milnes Tally Largent; Yamamura Henry I; Vanderah Todd W; Roeske William R; Varga Eva V
Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia.
European journal of pharmacology 2008;601(1-3):207-8.
2008: Fioravanti Beatriz; De Felice Milena; Stucky Cheryl L; Medler Karen A; Luo Miaw-Chyi; Gardell Luis R; Ibrahim Mohab; Malan T Phil; Yamamura Henry I; Ossipov Michael H; King Tamara; Lai Josephine; Porreca Frank; Vanderah Todd W
Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(45):11593-602.
2008: Yamamoto Takashi; Nair Padma; Jacobsen Neil E; Davis Peg; Ma Shou-wu; Navratilova Edita; Moye Sharif; Lai Josephine; Yamamura Henry I; Vanderah Todd W; Porreca Frank; Hruby Victor J
The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
Journal of medicinal chemistry 2008;51(20):6334-47.
2008: Yue Xu; Tumati Suneeta; Navratilova Edita; Strop Dagmar; St John Paul A; Vanderah Todd W; Roeske William R; Yamamura Henry I; Varga Eva V
Sustained morphine treatment augments basal CGRP release from cultured primary sensory neurons in a Raf-1 dependent manner.
European journal of pharmacology 2008;584(2-3):272-7.
2008: Yamamoto Takashi; Nair Padma; Vagner Josef; Largent-Milnes Tally; Davis Peg; Ma Shou-Wu; Navratilova Edita; Moye Sharif; Tumati Suneeta; Lai Josephine; Yamamura Henry I; Vanderah Todd W; Porreca Frank; Hruby Victor J
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
Journal of medicinal chemistry 2008;51(5):1369-76.
2008: Georgieva Teodora; Devanathan Savitha; Stropova Dagmar; Park Chad K; Salamon Zdzislaw; Tollin Gordon; Hruby Victor J; Roeske William R; Yamamura Henry I; Varga Eva
Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling.
European journal of pharmacology 2008;581(1-2):19-29.
2007: Yamamoto Takashi; Nair Padma; Davis Peg; Ma Shou-wu; Navratilova Edita; Moye Sharif; Tumati Suneeta; Lai Josephine; Vanderah Todd W; Yamamura Henry I; Porreca Frank; Hruby Victor J
Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.
Journal of medicinal chemistry 2007;50(12):2779-86.
2007: Nissan Hani P; Lu Jian; Booth Nancy L; Yamamura Henry I; Farnsworth Norman R; Wang Z Jim
A red clover (Trifolium pratense) phase II clinical extract possesses opiate activity.
Journal of ethnopharmacology 2007;112(1):207-10.
2007: Navratilova Edita; Waite Sue; Stropova Dagmar; Eaton Miriam C; Alves Isabel D; Hruby Victor J; Roeske William R; Yamamura Henry I; Varga Eva V
Quantitative evaluation of human delta opioid receptor desensitization using the operational model of drug action.
Molecular pharmacology 2007;71(5):1416-26.
2006: Cai Minying; Varga Eva V; Stankova Magda; Mayorov Alexander; Perry Joseph W; Yamamura Henry I; Trivedi Dev; Hruby Victor J
Cell signaling and trafficking of human melanocortin receptors in real time using two-photon fluorescence and confocal laser microscopy: differentiation of agonists and antagonists.
Chemical biology & drug design 2006;68(4):183-93.
2006: Yue Xu; Varga Eva V; Stropova Dagmar; Vanderah Todd W; Yamamura Henry I; Roeske William R
Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074.
European journal of pharmacology 2006;540(1-3):57-9.
2006: Oki Tomomi; Maruyama Shuji; Takagi Yukiko; Yamamura Henry I; Yamada Shizuo
Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
European journal of pharmacology 2006;529(1-3):157-63.
2006: Hruby Victor J; Porreca Frank; Yamamura Henry I; Tollin Gordon; Agnes Richard S; Lee Yeon Sun; Cai Minying; Alves Isabel; Cowell Scott; Varga Eva; Davis Peg; Salamon Zdzislaw; Roeske William; Vanderah Todd; Lai Josephine
New paradigms and tools in drug design for pain and addiction.
The AAPS journal 2006;8(3):E450-60.
2005: Smith Emily A; Coym Jason W; Cowell Scott M; Tokimoto Takahira; Hruby Victor J; Yamamura Henry I; Wirth Mary J
Lipid bilayers on polyacrylamide brushes for inclusion of membrane proteins.
Langmuir : the ACS journal of surfaces and colloids 2005;21(21):9644-50.
2005: Navratilova Edita; Eaton Miriam C; Stropova Dagmar; Varga Eva V; Vanderah Todd W; Roeske William R; Yamamura Henry I
Morphine promotes phosphorylation of the human delta-opioid receptor at serine 363.
European journal of pharmacology 2005;519(3):212-4.
2005: Handl Heather L; Vagner Josef; Yamamura Henry I; Hruby Victor J; Gillies Robert J
Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor.
Analytical biochemistry 2005;343(2):299-307.
2005: Dhanasekaran Muthu; Palian Michael M; Alves Isabel; Yeomans Larisa; Keyari Charles M; Davis Peg; Bilsky Edward J; Egleton Richard D; Yamamura Henry I; Jacobsen Neil E; Tollin Gordon; Hruby Victor J; Porreca Frank; Polt Robin
Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayers.
Journal of the American Chemical Society 2005;127(15):5435-48.
2005: Varga Eva V; Hosohata Keiko; Borys Dariusz; Navratilova Edita; Nylen Anders; Vanderah Todd W; Porreca Frank; Roeske William R; Yamamura Henry I
Antinociception depends on the presence of G protein gamma2-subunits in brain.
European journal of pharmacology 2005;508(1-3):93-8.
2005: Gu Xuyuan; Ying Jinfa; Min Byoung; Cain James P; Davis Peg; Willey Patrick; Navratilova Edita; Yamamura Henry I; Porreca Frank; Hruby Victor J
Parallel synthesis and biological evaluation of different sizes of bicyclo[2,3]-Leu-enkephalin analogues.
Biopolymers 2005;80(2-3):151-63.
2004: Varga Eva V; Navratilova Edita; Stropova Dagmar; Jambrosic Janelle; Roeske William R; Yamamura Henry I
Agonist-specific regulation of the delta-opioid receptor.
Life sciences 2004;76(6):599-612.
2004: Alves Isabel D; Ciano Kathy A; Boguslavski Valentina; Varga Eva; Salamon Zdzislaw; Yamamura Henry I; Hruby Victor J; Tollin Gordon
Selectivity, cooperativity, and reciprocity in the interactions between the delta-opioid receptor, its ligands, and G-proteins.
The Journal of biological chemistry 2004;279(43):44673-82.
2004: Elmagbari Nura O; Egleton Richard D; Palian Michael M; Lowery John J; Schmid Wendi R; Davis Peg; Navratilova Edita; Dhanasekaran Muthu; Keyari Charles M; Yamamura Henry I; Porreca Frank; Hruby Victor J; Polt Robin; Bilsky Edward J
Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides.
The Journal of pharmacology and experimental therapeutics 2004;311(1):290-7.
2004: Gu Xuyuan; Ying Jinfa; Agnes Richard S; Navratilova Edita; Davis Peg; Stahl Gannon; Porreca Frank; Yamamura Henry I; Hruby Victor J
Novel design of bicyclic beta-turn dipeptides on solid-phase supports and synthesis of [3.3.0]-Bicyclo([2,3])-leu-enkephalin analogues.
Organic letters 2004;6(19):3285-8.
2004: Handl Heather L; Vagner Josef; Yamamura Henry I; Hruby Victor J; Gillies Robert J
Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
Analytical biochemistry 2004;330(2):242-50.
2004: Cai Minying; Stankova Magda; Pond Stephanie J K; Mayorov Alexander V; Perry Joseph W; Yamamura Henry I; Trivedi Dev; Hruby Victor J
Real time differentiation of G-protein coupled receptor (GPCR) agonist and antagonist by two photon fluorescence laser microscopy.
Journal of the American Chemical Society 2004;126(23):7160-1.
2004: Navratilova Edita; Varga Eva V; Stropova Dagmar; Jambrosic Janelle C; Roeske William R; Yamamura Henry I
Mutation S363A in the human delta-opioid receptor selectively reduces down-regulation by a peptide agonist.
European journal of pharmacology 2004;485(1-3):341-3.
2003: Varga Eva V; Yamamura Henry I; Rubenzik Marc K; Stropova Dagmar; Navratilova Edita; Roeske William R
Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment.
Life sciences 2003;74(2-3):299-311.
2003: Alves Isabel D; Salamon Zdzislaw; Varga Eva; Yamamura Henry I; Tollin Gordon; Hruby Victor J
Direct observation of G-protein binding to the human delta-opioid receptor using plasmon-waveguide resonance spectroscopy.
The Journal of biological chemistry 2003;278(49):48890-7.
2003: Varga Eva V; Rubenzik Marc K; Stropova Dagmar; Sugiyama Masano; Grife Vanessa; Hruby Victor J; Rice Kenner C; Roeske William R; Yamamura Henry I
Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment.
The Journal of pharmacology and experimental therapeutics 2003;306(1):109-15.
2003: Hosohata Keiko; Varga Eva V; Alfaro-Lopez Josue; Tang Xuejun; Vanderah Todd W; Porreca Frank; Hruby Victor J; Roeske William R; Yamamura Henry I
(2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
The Journal of pharmacology and experimental therapeutics 2003;304(2):683-8.
2003: Okura Takashi; Varga Eva V; Hosohata Yoshiaki; Navratilova Edita; Cowell Scott M; Rice Kenner; Nagase Hiroshi; Hruby Victor J; Roeske William R; Yamamura Henry I
Agonist-specific down-regulation of the human delta-opioid receptor.
European journal of pharmacology 2003;459(1):9-16.
2002: Varga Eva V; Rubenzik Marc; Grife Vanessa; Sugiyama Masano; Stropova Dagmar; Roeske William R; Yamamura Henry I
Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation.
European journal of pharmacology 2002;451(1):101-2.
2001: Stamer W D; Golightly S F; Hosohata Y; Ryan E P; Porter A C; Varga E; Noecker R J; Felder C C; Yamamura H I
Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
European journal of pharmacology 2001;431(3):277-86.
2001: Rubenzik M; Varga E; Stropova D; Roeske W R; Yamamura H I
Expression of alpha-transducin in Chinese hamster ovary cells stably transfected with the human delta-opioid receptor attenuates chronic opioid agonist-induced adenylyl cyclase superactivation.
Molecular pharmacology 2001;60(5):1076-82.
2001: Witt K A; Huber J D; Egleton R D; Roberts M J; Bentley M D; Guo L; Wei H; Yamamura H I; Davis T P
Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen2, D-Pen5]-enkephalin (DPDPE).
The Journal of pharmacology and experimental therapeutics 2001;298(2):848-56.
2001: Hosohata Y; Varga E V; Stropova D; Li X; Knapp R J; Hruby V J; Rice K C; Nagase H; Roeske W R; Yamamura H I
Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activation.
Life sciences 2001;68(19-20):2233-42.
2001: Liao S; Shenderovich M; Kövér K E; Zhang Z; Hosohata K; Davis P; Porreca F; Yamamura H I; Hurby V J
Synthesis, biology, NMR and conformation studies of the topographically constrained delta-opioid selective peptide analogs of [beta-iPrPhe(3)]deltorphin I.
The journal of peptide research : official journal of the American Peptide Society 2001;57(4):257-76.
2001: Lipkowski A W; Misicka A; Hosohata K; Davis P; Yamamura H I; Porreca F; Hruby V J
Biological properties of Phe(o)-opioid peptide analogues.
Life sciences 2001;68(8):969-72.
2000: Salamon Z; Cowell S; Varga E; Yamamura H I; Hruby V J; Tollin G
Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions.
Biophysical journal 2000;79(5):2463-74.
2000: Egleton R D; Mitchell S A; Huber J D; Janders J; Stropova D; Polt R; Yamamura H I; Hruby V J; Davis T P
Improved bioavailability to the brain of glycosylated Met-enkephalin analogs.
Brain research 2000;881(1):37-46.
2000: Witt K A; Slate C A; Egleton R D; Huber J D; Yamamura H I; Hruby V J; Davis T P
Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin.
Journal of neurochemistry 2000;75(1):424-35.
2000: Bilsky E J; Egleton R D; Mitchell S A; Palian M M; Davis P; Huber J D; Jones H; Yamamura H I; Janders J; Davis T P; Porreca F; Hruby V J; Polt R
Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability.
Journal of medicinal chemistry 2000;43(13):2586-90.
2000: Hosohata K; Logan J K; Varga E; Burkey T H; Vanderah T W; Porreca F; Hruby V J; Roeske W R; Yamamura H I
The role of the G protein gamma(2) subunit in opioid antinociception in mice.
European journal of pharmacology 2000;392(3):R9-R11.
2000: Bonner G G; Davis P; Stropova D; Edsall S; Yamamura H I; Porreca F; Hruby V J
Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
Journal of medicinal chemistry 2000;43(4):569-80.
2000: Hosohata Y; Vanderah T W; Burkey T H; Ossipov M H; Kovelowski C J; Sora I; Uhl G R; Zhang X; Rice K C; Roeske W R; Hruby V J; Yamamura H I; Lai J; Porreca F
delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
European journal of pharmacology 2000;388(3):241-8.
2000: Okura T; Cowell S M; Varga E; Burkey T H; Roeske W R; Hruby V J; Yamamura H I
Differential down-regulation of the human delta-opioid receptor by SNC80 and [D-Pen(2),D-Pen(5)]enkephalin.
European journal of pharmacology 2000;387(2):R11-3.
2000: Varga E V; Stropova D; Kim T; Wang M; Roeske W R; Yamamura H I
Coupling of human delta-opioid receptor to retinal rod transducin in Chinese hamster ovary cells.
The Journal of pharmacology and experimental therapeutics 2000;292(1):209-14.
1999: Alfaro-Lopez J; Okayama T; Hosohata K; Davis P; Porreca F; Yamamura H I; Hruby V J
Exploring the structure-activity relationships of [1-(4-tert-butyl-3'-hydroxy)benzhydryl-4-benzylpiperazine] (SL-3111), a high-affinity and selective delta-opioid receptor nonpeptide agonist ligand.
Journal of medicinal chemistry 1999;42(26):5359-68.
1999: Hosohata K; Burkey T H; Alfaro-Lopez J; Hruby V J; Roeske W R; Yamamura H I
(2S,3R)TMT-L-Tic-OH is a potent inverse agonist at the human delta-opioid receptor.
European journal of pharmacology 1999;380(1):R9-10.
1999: Lipkowski A W; Misicka A; Davis P; Stropova D; Janders J; Lachwa M; Porreca F; Yamamura H I; Hruby V J
Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin.
Bioorganic & medicinal chemistry letters 1999;9(18):2763-6.
1999: Quock R M; Burkey T H; Varga E; Hosohata Y; Hosohata K; Cowell S M; Slate C A; Ehlert F J; Roeske W R; Yamamura H I
The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy.
Pharmacological reviews 1999;51(3):503-32.
1999: LeVan T D; Babin E A; Yamamura H I; Bloom J W
Pharmacological characterization of glucocorticoid receptors in primary human bronchial epithelial cells.
Biochemical pharmacology 1999;57(9):1003-9.
1999: Bartosz-Bechowski H; Davis P; Slaninova J; Malatynska E; Stropova D; Porreca F; Yamamura H I; Hruby V J
Cyclic enkephalin analogs that are hybrids of DPDPE-related peptides and metenkephalin-Arg-Gly-Leu: prohormone analogs that retain good potency and selectivity for delta opioid receptors.
The journal of peptide research : official journal of the American Peptide Society 1999;53(3):329-36.
1999: Varga E V; Stropova D; Rubenzik M; Waite S; Roeske W R; Yamamura H I
Phosphorylation of adenylyl cyclase VI upon chronic delta-opioid receptor stimulation.
European journal of pharmacology 1999;364(2-3):R1-3.
1998: Liao S; Alfaro-Lopez J; Shenderovich M D; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan K A; Porreca F; Yamamura H I; Hruby V J
De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
Journal of medicinal chemistry 1998;41(24):4767-76.
1998: Malatynska E; Waite S; Wei H B; Knapp R J; Yamamura H I; Roeske W R
Structural correlates for down-regulation of m1 and m2 muscarinic receptor subtypes.
Brain research bulletin 1998;47(3):285-90.
1998: Varga E V; Stropova D; Rubenzik M; Wang M; Landsman R S; Roeske W R; Yamamura H I
Identification of adenylyl cyclase isoenzymes in CHO and B82 cells.
European journal of pharmacology 1998;348(2-3):R1-2.
1998: Hosohata K; Burkey T H; Alfaro-Lopez J; Varga E; Hruby V J; Roeske W R; Yamamura H I
Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor.
European journal of pharmacology 1998;346(1):111-4.
1998: Li G; Haq W; Xiang L; Lou B S; Hughes R; De Leon I A; Davis P; Gillespie T J; Romanowski M; Zhu X; Misicka A; Lipkowski A W; Porreca F; Davis T P; Yamamura H I; O'Brien D F; Hruby V J
Modifications of the 4,4'-residues and SAR studies of Biphalin, a highly potent opioid receptor active peptide.
Bioorganic & medicinal chemistry letters 1998;8(5):555-60.
1998: Kovacs I; Yamamura H I; Waite S L; Varga E V; Roeske W R
Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line.
The Journal of pharmacology and experimental therapeutics 1998;284(2):500-7.
1998: Burkey T H; Ehlert F J; Hosohata Y; Quock R M; Cowell S; Hosohata K; Varga E; Stropova D; Li X; Slate C; Nagase H; Porreca F; Hruby V J; Roeske W R; Yamamura H I
The efficacy of delta-opioid receptor-selective drugs.
Life sciences 1998;62(17-18):1531-6.
1998: Slaninova J; Appleyard S M; Misicka A; Lipkowski A W; Knapp R J; Weber S J; Davis T P; Yamamura H I; Hruby V J
[125I-Tyr1]biphalin binding to opioid receptors of rat brain and NG108-15 cell membranes.
Life sciences 1998;62(14):PL199-204.
1998: Landsman R S; Makriyannis A; Deng H; Consroe P; Roeske W R; Yamamura H I
AM630 is an inverse agonist at the human cannabinoid CB1 receptor.
Life sciences 1998;62(9):PL109-13.
1997: Hruby V J; Bartosz-Bechowski H; Davis P; Slaninova J; Zalewska T; Stropova D; Porreca F; Yamamura H I
Cyclic enkephalin analogues with exceptional potency and selectivity for delta-opioid receptors.
Journal of medicinal chemistry 1997;40(24):3957-62.
1997: Burkey T H; Quock R M; Consroe P; Ehlert F J; Hosohata Y; Roeske W R; Yamamura H I
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.
European journal of pharmacology 1997;336(2-3):295-8.
1997: Landsman R S; Burkey T H; Consroe P; Roeske W R; Yamamura H I
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor.
European journal of pharmacology 1997;334(1):R1-2.
1997: Haaseth R C; Zalewska T; Davis P; Yamamura H I; Porreca F; Hruby V J
Para-substituted phenylalanine-4 analogues of [L-Ala3]DPDPE: highly selective delta opioid receptor ligands.
The journal of peptide research : official journal of the American Peptide Society 1997;50(3):171-7.
1997: Katsura Y; Zhang X; Homma K; Rice K C; Calderon S N; Rothman R B; Yamamura H I; Davis P; Flippen-Anderson J L; Xu H; Becketts K; Foltz E J; Porreca F
Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Journal of medicinal chemistry 1997;40(18):2936-47.
1997: Misicka A; Cavagnero S; Horvath R; Davis P; Porreca F; Yamamura H I; Hruby V J
Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptors.
The journal of peptide research : official journal of the American Peptide Society 1997;50(1):48-54.
1997: Quock R M; Hosohata Y; Knapp R J; Burkey T H; Hosohata K; Zhang X; Rice K C; Nagase H; Hruby V J; Porreca F; Roeske W R; Yamamura H I
Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor.
European journal of pharmacology 1997;326(1):101-4.
1997: Patel D; McKinley B D; Davis T P; Porreca F; Yamamura H I; Hruby V J
Peptide targeting and delivery across the blood-brain barrier utilizing synthetic triglyceride esters: design, synthesis, and bioactivity.
Bioconjugate chemistry 1997;8(3):434-41.
1997: Burkey T H; Quock R M; Consroe P; Roeske W R; Yamamura H I
delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.
European journal of pharmacology 1997;323(2-3):R3-4.
1997: Hosohata Y; Quock R M; Hosohata K; Makriyannis A; Consroe P; Roeske W R; Yamamura H I
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain.
European journal of pharmacology 1997;321(1):R1-3.
1997: Hosohata K; Quock R M; Hosohata Y; Burkey T H; Makriyannis A; Consroe P; Roeske W R; Yamamura H I
AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain.
Life sciences 1997;61(9):PL115-8.
1997: Bonner G G; Davis P; Stropova D; Ferguson R; Yamamura H I; Porreca F; Hruby V J
Opioid peptides: simultaneous delta agonism and mu antagonism in somatostatin analogues.
Peptides 1997;18(1):93-100.
1997: Misicka A; Lipkowski A W; Horvath R; Davis P; Porreca F; Yamamura H I; Hruby V J
Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4.
Life sciences 1997;60(15):1263-9.
1996: Varga E V; Li X; Stropova D; Zalewska T; Landsman R S; Knapp R J; Malatynska E; Kawai K; Mizusura A; Nagase H; Calderon S N; Rice K; Hruby V J; Roeske W R; Yamamura H I
The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.
Molecular pharmacology 1996;50(6):1619-24.
1996: Boteju L W; Nikiforovich G V; Haskell-Luevano C; Fang S N; Zalewska T; Stropova D; Yamamura H I; Hruby V J
The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Journal of medicinal chemistry 1996;39(20):4120-4.
1996: Malatynska E; Wang Y; Knapp R J; Waite S; Calderon S; Rice K; Hruby V J; Yamamura H I; Roeske W R
Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.
The Journal of pharmacology and experimental therapeutics 1996;278(3):1083-9.
1996: Qian X; Liao S; Stropova D; Yamamura H I; Hruby V J
Novel scaffolds for non-peptide mimetics of delta opioid receptor agonists based on peptide leads.
Regulatory peptides 1996;65(1):79-82.
1996: Vanderah T W; Bernstein R N; Yamamura H I; Hruby V J; Porreca F
Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
The Journal of pharmacology and experimental therapeutics 1996;278(1):212-9.
1996: Lung F D; Meyer J P; Lou B S; Xiang L; Li G; Davis P; DeLeon I A; Yamamura H I; Porreca F; Hruby V J
Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
Journal of medicinal chemistry 1996;39(13):2456-60.
1996: Knapp R J; Santoro G; De Leon I A; Lee K B; Edsall S A; Waite S; Malatynska E; Varga E; Calderon S N; Rice K C; Rothman R B; Porreca F; Roeske W R; Yamamura H I
Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
The Journal of pharmacology and experimental therapeutics 1996;277(3):1284-91.
1996: Li X; Varga E V; Stropova D; Zalewska T; Malatynska E; Knapp R J; Roeske W R; Yamamura H I
delta-Opioid receptor: the third extracellular loop determines naltrindole selectivity.
European journal of pharmacology 1996;300(1-2):R1-2.
1996: Lung F D; Collins N; Stropova D; Davis P; Yamamura H I; Porreca F; Hruby V J
Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
Journal of medicinal chemistry 1996;39(5):1136-41.
1996: Millard S L; Bloom J W; Yamamura H I
Heterogeneity of tachykinin receptors in the rabbit lung.
Neurochemical research 1996;21(2):277-83.
1996: Edsall S A; Knapp R J; Vanderah T W; Roeske W R; Consroe P; Yamamura H I
Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception.
Neuroreport 1996;7(2):593-6.
1996: Misicka A; Maszczynska I; Lipkowski A W; Stropova D; Yamamura H I; Hruby V J
Synthesis and biological properties of gamma-glutamyl-dermorphin, a prodrug.
Life sciences 1996;58(11):905-11.
1995: Knapp R J; Landsman R; Waite S; Malatynska E; Varga E; Haq W; Hruby V J; Roeske W R; Nagase H; Yamamura H I
Properties of TAN-67, a nonpeptidic delta-opioid receptor agonist, at cloned human delta- and mu-opioid receptors.
European journal of pharmacology 1995;291(2):129-34.
1995: Meyer J P; Davis P; Lee K B; Porreca F; Yamamura H I; Hruby V J
Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1.
Journal of medicinal chemistry 1995;38(18):3462-8.
1995: Malatynska E; Knapp R J; Stropova D; Varga E; Yamamura H I
The role of the Val353 residue in antagonist binding to rat CCK-B receptors.
Neuroreport 1995;6(9):1325-9.
1995: Hruby V J; Yamamura H I; Porreca F
Molecular organization of receptors. Efficacy, agonists, and antagonists.
Annals of the New York Academy of Sciences 1995;757():7-22.
1995: Knapp R J; Malatynska E; Collins N; Fang L; Wang J Y; Hruby V J; Roeske W R; Yamamura H I
Molecular biology and pharmacology of cloned opioid receptors.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1995;9(7):516-25.
1995: Witt-Enderby P A; Yamamura H I; Halonen M; Lai J; Palmer J D; Bloom J W
Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
Molecular pharmacology 1995;47(3):485-90.
1995: Malatynska E; Wang Y; Knapp R J; Santoro G; Li X; Waite S; Roeske W R; Yamamura H I
Human delta opioid receptor: a stable cell line for functional studies of opioids.
Neuroreport 1995;6(4):613-6.
1995: Lung F D; Meyer J P; Li G; Lou B S; Stropova D; Davis P; Yamamura H I; Porreca F; Hruby V J
Highly kappa receptor-selective dynorphin A analogues with modifications in position 3 of dynorphin A(1-11)-NH2.
Journal of medicinal chemistry 1995;38(4):585-6.
1995: Slaninova J; Knapp R J; Weber S J; Davis T P; Fang S N; Hruby V J; Yamamura H I
[125I]SNF 8702: a selective radioligand for CCKB receptors.
Peptides 1995;16(2):221-4.
1995: Malatynska E; De Leon I; Allen D; Yamamura H I
Effects of amitriptyline on GABA-stimulated 36CI- uptake in relation to a behavioral model of depression.
Brain research bulletin 1995;37(1):53-9.
1995: Misicka A; Lipkowski A W; Slaninova J; Davis P; Yamamura H I; Porreca F; Hruby V J
The synthesis and opioid receptor binding affinities of analogues of dermorphin and its N-terminal tetrapeptide fragment with dibasic acids in position 2.
Life sciences 1995;57(18):1633-40.
1994: Wild K D; Porreca F; Yamamura H I; Raffa R B
Differentiation of receptor subtypes by thermodynamic analysis: application to opioid delta receptors.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(25):12018-21.
1994: Misicka A; Lipkowski A W; Horvath R; Davis P; Porreca F; Yamamura H I; Hruby V J
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analogues.
International journal of peptide and protein research 1994;44(6):607.
1994: Vanderah T W; Lai J; Yamamura H I; Porreca F
Antisense oligodeoxynucleotide to the CCKB receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception.
Neuroreport 1994;5(18):2601-5.
1994: Meyer J P; Collins N; Lung F D; Davis P; Zalewska T; Porreca F; Yamamura H I; Hruby V J
Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.
Journal of medicinal chemistry 1994;37(23):3910-7.
1994: Knapp R J; Malatynska E; Peterson P; Zalewska T; Fang S; Hruby V J; Smith T L; Yamamura H I
[N-methylnorleucine-(28,31)]cholecystokinin-(26-33) (SNF 8702) activity at a cloned rat CCKB receptor.
European journal of pharmacology 1994;269(2):133-8.
1994: Wei H B; Yamamura H I; Roeske W R
Down-regulation and desensitization of the muscarinic M1 and M2 receptors in transfected fibroblast B82 cells.
European journal of pharmacology 1994;268(3):381-91.
1994: Polt R; Porreca F; Szabò L Z; Bilsky E J; Davis P; Abbruscato T J; Davis T P; Harvath R; Yamamura H I; Hruby V J
Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(15):7114-8.
1994: Misicka A; Lipkowski A W; Horvath R; Davis P; Porreca F; Yamamura H I; Hruby V J
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analogues.
International journal of peptide and protein research 1994;44(1):80-4.
1994: Haaseth R C; Horan P J; Bilsky E J; Davis P; Zalewska T; Slaninova J; Yamamura H I; Weber S J; Davis T P; Porreca F
[L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity.
Journal of medicinal chemistry 1994;37(11):1572-7.
1994: Knapp R J; Malatynska E; Hashimoto S; Fang S; Hunt M; Wamsley J K; Peterson P; Zalewska T; Hruby V J; Yamamura H I
[3H]SNF8702 autoradiography of CCK-B receptors in guinea pig brain and studies with a cloned rat CCK-B receptor.
Annals of the New York Academy of Sciences 1994;713():380-3.
1994: Mania-Farnell B L; Merrill B J; Yamamura H I; Davis T P
Second messenger activators regulate CCK mRNA in the human neuroepithelioma cell line SK-N-MCIXC.
Annals of the New York Academy of Sciences 1994;713():446-8.
1994: Rao R K; Levenson S; Fang S N; Hruby V J; Yamamura H I; Porreca F
Role of substance P in the regulation of ion transport by CCKA and CCKB receptors in mouse ileum.
Annals of the New York Academy of Sciences 1994;713():420-1.
1994: Fang L; Knapp R J; Horvath R; Matsunaga T O; Haaseth R C; Hruby V J; Porreca F; Yamamura H I
Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
The Journal of pharmacology and experimental therapeutics 1994;268(2):836-46.
1994: Rao R K; Levenson S; Fang S N; Hruby V J; Yamamura H I; Porreca F
Characterization of SNF 9007, a novel cholecystokinin/opoid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transport.
The Journal of pharmacology and experimental therapeutics 1994;268(2):1003-9.
1994: Bartosz-Bechowski H; Davis P; Zalewska T; Slaninova J; Porreca F; Yamamura H I; Hruby V J
Cyclic enkephalin analogs with exceptional potency at peripheral delta opioid receptors.
Journal of medicinal chemistry 1994;37(1):146-50.
1994: Misicka A; Lipkowski A W; Horvath R; Davis P; Yamamura H I; Porreca F; Hruby V J
Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogues with high selectivity for delta-opioid receptors.
Journal of medicinal chemistry 1994;37(1):141-5.
1994: Ehlert F J; Roeske W R; Yamamura H I
Muscarinic receptors and novel strategies for the treatment of age-related brain disorders.
Life sciences 1994;55(25-26):2135-45.
1993: Kawasaki A M; Knapp R J; Walton A; Wire W S; Zalewska T; Yamamura H I; Porreca F; Burks T F; Hruby V J
Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10.
International journal of peptide and protein research 1993;42(5):411-9.
1993: Witt-Enderby P A; Yamamura H I; Halonen M; Palmer J D; Bloom J W
Chronic exposure to a beta 2-adrenoceptor agonist increases the airway response to methacholine.
European journal of pharmacology 1993;241(1):121-3.
1993: Wild K D; Fang L; McNutt R W; Chang K J; Toth G; Borsodi A; Yamamura H I; Porreca F
Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium.
European journal of pharmacology 1993;246(3):289-92.
1993: Millard S; Yamamura H; Bloom J
Characterization of NK-2 binding sites in rabbit lung tissue.
Regulatory peptides 1993;46(1-2):217-9.
1993: Wild K D; Horan P J; Misicka A; Lipkowski A; Haaseth R C; Matsunaga T O; Hruby V J; Toth G; Borsodi A; Yamamura H I
Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.
European journal of pharmacology 1993;246(1):25-31.
1993: Horan P J; Mattia A; Bilsky E J; Weber S; Davis T P; Yamamura H I; Malatynska E; Appleyard S M; Slaninova J; Misicka A
Antinociceptive profile of biphalin, a dimeric enkephalin analog.
The Journal of pharmacology and experimental therapeutics 1993;265(3):1446-54.
1993: Horan P J; Wild K D; Misicka A; Lipkowski A; Haaseth R C; Hruby V J; Weber S J; Davis T P; Yamamura H I; Porreca F
Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
The Journal of pharmacology and experimental therapeutics 1993;265(2):896-902.
1993: Henderson A K; Roeske W R; Smith T L; Yamamura H I
Desensitization of neurokinin A receptors expressed by B82 fibroblasts.
European journal of pharmacology 1993;245(1):75-8.
1993: Horan P J; Wild K D; Kazmierski W M; Ferguson R; Hruby V J; Weber S J; Davis T P; Fang L; Knapp R J; Yamamura H I
Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
European journal of pharmacology 1993;233(1):53-62.
1993: Kawasaki A M; Knapp R J; Kramer T H; Walton A; Wire W S; Hashimoto S; Yamamura H I; Porreca F; Burks T F; Hruby V J
Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.
Journal of medicinal chemistry 1993;36(6):750-7.
1993: Parola A L; Yamamura H I; Laird H E
Peripheral-type benzodiazepine receptors.
Life sciences 1993;52(16):1329-42.
1992: Weber S J; Greene D L; Hruby V J; Yamamura H I; Porreca F; Davis T P
Whole body and brain distribution of [3H]cyclic [D-Pen2,D-Pen5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1308-16.
1992: Sora I; Fujiwara Y; Tomita H; Ishizu H; Akiyama K; Otsuki S; Yamamura H I
Lack of effect of haloperidol or methamphetamine treatment on the mRNA levels of two dopamine D2 receptor isoforms in rat brain.
The Japanese journal of psychiatry and neurology 1992;46(4):967-73.
1992: Knapp R J; Yamamura H I
Delta opioid receptor radioligands.
Biochemical pharmacology 1992;44(9):1687-95.
1992: Lai J; Nunan L; Waite S L; Ma S W; Bloom J W; Roeske W R; Yamamura H I
Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
The Journal of pharmacology and experimental therapeutics 1992;262(1):173-80.
1992: Toth G; Russell K C; Landis G; Kramer T H; Fang L; Knapp R; Davis P; Burks T F; Yamamura H I; Hruby V J
Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
Journal of medicinal chemistry 1992;35(13):2384-91.
1992: Kazmierski W M; Ferguson R D; Knapp R J; Lui G K; Yamamura H I; Hruby V J
Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.
International journal of peptide and protein research 1992;39(5):401-14.
1992: Mahesh V K; Nunan L M; Halonen M; Yamamura H I; Palmer J D; Bloom J W
A minority of muscarinic receptors mediate rabbit tracheal smooth muscle contraction.
American journal of respiratory cell and molecular biology 1992;6(3):279-86.
1992: Horan P; Taylor J; Yamamura H I; Porreca F
Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1237-43.
1992: Tourwé D; Couder J; Ceusters M; Meert D; Burks T F; Kramer T H; Davis P; Knapp R; Yamamura H I; Leysen J E
Synthesis and biological activities of linear and cyclic enkephalin analogues containing a psi (E,CH = CH) or psi (CH2CH2) isosteric replacement.
International journal of peptide and protein research 1992;39(2):131-6.
1992: Henderson A K; Yamamura H I; Maggi C A; Buck S H; Van Giersbergen P L; Roeske W R
Demonstration of a neurokinin A receptor subtype in transfected fibroblasts.
European journal of pharmacology 1992;225(2):175-8.
1992: Fang L; Knapp R J; Matsunaga T; Weber S J; Davis T; Hruby V J; Yamamura H I
Synthesis of [D-Ala2,4'-125I-Phe3,Glu4]deltorphin and characterization of its delta opioid receptor binding properties.
Life sciences 1992;51(20):PL189-93.
1992: Misicka A; Lipkowski A W; Horvath R; Davis P; Kramer T H; Yamamura H I; Hruby V J
Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin.
Life sciences 1992;51(13):1025-32.
1992: Kashihara K; Varga E V; Waite S L; Roeske W R; Yamamura H I
Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes.
Life sciences 1992;51(12):955-71.
1992: Yamamura M S; Horvath R; Toth G; Otvos F; Malatynska E; Knapp R J; Porreca F; Hruby V J; Yamamura H I
Characterization of [3H]naltrindole binding to delta opioid receptors in rat brain.
Life sciences 1992;50(16):PL119-24.
1992: Wei H B; Roeske W R; Lai J; Wanibuchi F; Hidaka K; Usuda S; Yamamura H I
Pharmacological characterization of a novel muscarinic partial agonist, YM796, in transfected cells expressing the m1 or m2 muscarinic receptor gene.
Life sciences 1992;50(5):355-63.
1991: Fujiwara Y; Sora I; Tomita H; Akiyama K; Otsuki S; Yamamura H I
Localization of the mRNAs for two dopamine D2 receptor isoforms in the rat brain.
The Japanese journal of psychiatry and neurology 1991;45(4):897-902.
1991: Weber S J; Greene D L; Sharma S D; Yamamura H I; Kramer T H; Burks T F; Hruby V J; Hersh L B; Davis T P
Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration.
The Journal of pharmacology and experimental therapeutics 1991;259(3):1109-17.
1991: Misicka A; Lipkowski A W; Fang L; Knapp R J; Davis P; Kramer T; Burks T F; Yamamura H I; Carr D B; Hruby V J
Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activity.
Biochemical and biophysical research communications 1991;180(3):1290-7.
1991: Lai J; Waite S L; Bloom J W; Yamamura H I; Roeske W R
The m2 muscarinic acetylcholine receptors are coupled to multiple signaling pathways via pertussis toxin-sensitive guanine nucleotide regulatory proteins.
The Journal of pharmacology and experimental therapeutics 1991;258(3):938-44.
1991: Slaninova J; Knapp R J; Wu J J; Fang S N; Kramer T; Burks T F; Hruby V J; Yamamura H I
Opioid receptor binding properties of analgesic analogues of cholecystokinin octapeptide.
European journal of pharmacology 1991;200(1):195-8.
1991: Davis T P; Gillespie T J; Shook J; Kramer T H; Hoyer G; Hawkins K; Davis P; Yamamura H I; Burks T F
Changes in opioid receptor selectivity following processing of peptide E: effect on gut motility.
Gastroenterology 1991;100(6):1603-15.
1991: Hruby V J; Toth G; Gehrig C A; Kao L F; Knapp R; Lui G K; Yamamura H I; Kramer T H; Davis P; Burks T F
Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
Journal of medicinal chemistry 1991;34(6):1823-30.
1991: van Giersbergen P L; Shatzer S A; Henderson A K; Lai J; Nakanishi S; Yamamura H I; Buck S H
Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(5):1661-5.
1991: Henderson A K; Yamamura H I; Maggi C A; Roeske W R; Smith T L
Neurokinin A receptors are coupled to calcium mobilization in transfected fibroblasts.
European journal of pharmacology 1991;206(3):251-3.
1991: Mei L; Lai J; Yamamura H I; Roeske W R
Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82).
The Journal of pharmacology and experimental therapeutics 1991;256(2):689-94.
1991: Lai J; Smith T L; Mei L; Ikeda M; Fujiwara Y; Gomez J; Halonen M; Roeske W R; Yamamura H I
The molecular properties of the M1 muscarinic receptor and its regulation of cytosolic calcium in a eukaryotic gene expression system.
Advances in experimental medicine and biology 1991;287():313-30.
1991: Cavagnero S; Misicka A; Knapp R J; Davis P; Fang L; Burks T F; Yamamura H I; Hruby V J
Delta opioid receptor-selective ligands: [D-Pen2,D-Pen5]enkephalin-dermenkephalin chimeric peptides.
Life sciences 1991;49(7):495-503.
1990: Knapp R J; Vaughn L K; Fang S N; Bogert C L; Yamamura M S; Hruby V J; Yamamura H I
A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
The Journal of pharmacology and experimental therapeutics 1990;255(3):1278-86.
1990: Gomez J; Bloom J W; Yamamura H I; Halonen M
Characterization of receptors for platelet-activating factor in guinea pig lung membranes.
American journal of respiratory cell and molecular biology 1990;3(3):259-64.
1990: Kawasaki A M; Knapp R J; Kramer T H; Wire W S; Vasquez O S; Yamamura H I; Burks T F; Hruby V J
Design and synthesis of highly potent and selective cyclic dynorphin A analogues.
Journal of medicinal chemistry 1990;33(7):1874-9.
1990: Hruby V J; Fang S A; Knapp R; Kazmierski W; Lui G K; Yamamura H I
Cholecystokinin analogues with high affinity and selectivity for brain membrane receptors.
International journal of peptide and protein research 1990;35(6):566-73.
1990: Mei L; Roeske W R; Izutsu K T; Yamamura H I
Characterization of muscarinic acetylcholine receptors in human labial salivary glands.
European journal of pharmacology 1990;176(3):367-70.
1990: Vaughn L K; Wire W S; Davis P; Shimohigashi Y; Toth G; Knapp R J; Hruby V J; Burks T F; Yamamura H I
Differentiation between rat brain and mouse vas deferens delta opioid receptors.
European journal of pharmacology 1990;177(1-2):99-101.
1990: Knapp R J; Malatynska E; Yamamura H I
From binding studies to the molecular biology of GABA receptors.
Neurochemical research 1990;15(2):105-12.
1990: Toth G; Kramer T H; Knapp R; Lui G; Davis P; Burks T F; Yamamura H I; Hruby V J
[D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptors.
Journal of medicinal chemistry 1990;33(1):249-53.
1990: Fujiwara Y; Nelson D L; Kashihara K; Varga E; Roeske W R; Yamamura H I
The cloning and sequence analysis of the rat serotonin-1A receptor gene.
Life sciences 1990;47(22):PL127-32.
1990: Lai J; Bloom J W; Yamamura H I; Roeske W R
Amplification of the rat M2 muscarinic receptor gene by the polymerase chain reaction: functional expression of the M2 muscarinic receptor.
Life sciences 1990;47(12):1001-13.
1990: Knapp R J; Yamamura H I
[3H][D-Pen2, D-Pen5]enkephalin binding to delta opioid receptors on intact neuroblastoma-glioma (NG 108-15) hybrid cells.
Life sciences 1990;46(20):1457-63.
1989: Mei L; Roeske W R; Yamamura H I
The coupling of muscarinic receptors to hydrolysis of inositol lipids in human neuroblastoma SH-SY5Y cells.
Brain research 1989;504(1):7-14.
1989: Mei L; Lai J; Yamamura H I; Roeske W R
The relationship between agonist states of the M1 muscarinic receptor and the hydrolysis of inositol lipids in transfected murine fibroblast cells (B82) expressing different receptor densities.
The Journal of pharmacology and experimental therapeutics 1989;251(1):90-7.
1989: Palfreyman M G; Dudley M W; Cheng H C; Mir A K; Yamada S; Roeske W R; Obata T; Yamamura H I
Lactamimides: a novel chemical class of calcium antagonists with diltiazem-like properties.
Biochemical pharmacology 1989;38(15):2459-65.
1989: Speth R C; Mei L; Yamamura H I
Angiotensin II receptor binding and actions in NG108-15 cells.
Peptide research 1989;2(3):232-9.
1989: Fujiwara Y; Bloom J W; Mantione C R; Yamamura H I
Identification of B2 bradykinin binding sites in the guinea pig nasal turbinate.
Peptides 1989;10(3):701-3.
1989: Malatynska E; Knapp R; Ikeda M; Yamamura H I
Beta-carboline interactions at the BZ-GABA receptor chloride-ionophore complex in the rat cerebral cortex.
Brain research bulletin 1989;22(5):845-8.
1989: Landis G; Lui G; Shook J E; Yamamura H I; Burks T F; Hruby V J
Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group.
Journal of medicinal chemistry 1989;32(3):638-43.
1989: Knapp R J; Kazmierski W; Hruby V J; Yamamura H I
Structural characteristics of two highly selective opioid peptides.
BioEssays : news and reviews in molecular, cellular and developmental biology 1989;10(2-3):58-61.
1989: Mei L; Lai J; Roeske W R; Fraser C M; Venter J C; Yamamura H I
Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
The Journal of pharmacology and experimental therapeutics 1989;248(2):661-70.
1989: Wang J X; Roeske W R; Hawkins K N; Gehlert D R; Yamamura H I
Quantitative autoradiography of M2 muscarinic receptors in the rat brain identified by using a selective radioligand [3H]AF-DX 116.
Brain research 1989;477(1-2):322-6.
1989: Hawkins K N; Knapp R J; Lui G K; Gulya K; Kazmierski W; Wan Y P; Pelton J T; Hruby V J; Yamamura H I
[3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
The Journal of pharmacology and experimental therapeutics 1989;248(1):73-80.
1989: Ikeda M; Weber K H; Bechtel W D; Malatynska E; Yamamura H I
Relative efficacies of 1,4-diazepines on GABA-stimulated chloride influx in rat brain vesicles.
Life sciences 1989;45(4):349-58.
1989: Ikeda M; Knapp R J; Malatynska E; Yamamura H I
Amoxapine inhibition of GABA-stimulated chloride conductance: investigations of potential sites of activity.
Life sciences 1989;45(20):1903-10.
1989: Vaughn L K; Knapp R J; Toth G; Wan Y P; Hruby V J; Yamamura H I
A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalin.
Life sciences 1989;45(11):1001-8.
1989: Fujiwara Y; Mantione C R; Vavrek R J; Stewart J M; Yamamura H I
Characterization of [3H]bradykinin binding sites in guinea-pig central nervous system: possible existence of B2 subtypes.
Life sciences 1989;44(22):1645-53.
1989: Mei L; Roeske W R; Yamamura H I
Molecular pharmacology of muscarinic receptor heterogeneity.
Life sciences 1989;45(20):1831-51.
1988: Bloom J W; Baumgartener-Folkerts C; Palmer J D; Yamamura H I; Halonen M
A muscarinic receptor subtype modulates vagally stimulated bronchial contraction.
Journal of applied physiology (Bethesda, Md. : 1985) 1988;65(5):2144-50.
1988: Kazmierski W; Wire W S; Lui G K; Knapp R J; Shook J E; Burks T F; Yamamura H I; Hruby V J
Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.
Journal of medicinal chemistry 1988;31(11):2170-7.
1988: Wang J X; Yamamura H I; Wang W; Roeske W R
Irreversible inhibition by tyrosine-directed alkylating reagents of muscarinic cholinergic receptors in membranes from rat forebrain and heart.
Biochemical pharmacology 1988;37(19):3787-90.
1988: Berzetei I P; Fong A; Yamamura H I; Duckles S P
Characterization of kappa opioid receptors in the rabbit ear artery.
European journal of pharmacology 1988;151(3):449-55.
1988: Yamada S; Yamazawa T; Harada Y; Yamamura H I; Nakayama K
Muscarinic receptor subtype in porcine coronary artery.
European journal of pharmacology 1988;150(3):373-6.
1988: Sugg E E; Serra M; Shook J E; Yamamura H I; Burks T F; Korc M; Hruby V J
Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue.
International journal of peptide and protein research 1988;31(6):514-9.
1988: Mei L; Yamamura H I; Roeske W R
Muscarinic receptor-mediated hydrolysis of phosphatidylinositols in human neuroblastoma (SH-SY5Y) cells is sensitive to pertussis toxin.
Brain research 1988;447(2):360-3.
1988: Serra M; Mei L; Roeske W R; Lui G K; Watson M; Yamamura H I
The intact human neuroblastoma cell (SH-SY5Y) exhibits high-affinity [3H]pirenzepine binding associated with hydrolysis of phosphatidylinositols.
Journal of neurochemistry 1988;50(5):1513-21.
1988: Wang J X; Roeske W R; Wang W; Yamamura H I
Himbacine recognizes a high affinity subtype of M2 muscarinic cholinergic receptors in the rat cerebral cortex.
Brain research 1988;446(1):155-8.
1988: Malatynska E; Serra M; Ikeda M; Biggio G; Yamamura H I
Modulation of GABA-stimulated chloride influx by beta-carbolines in rat brain membrane vesicles.
Brain research 1988;443(1-2):395-7.
1988: Fujiwara Y; Mantione C R; Yamamura H I
Identification of B2 bradykinin binding sites in guinea-pig brain.
European journal of pharmacology 1988;147(3):487-8.
1988: Obata T; Yamamura H I; Malatynska E; Ikeda M; Laird H; Palmer C J; Casida J E
Modulation of gamma-aminobutyric acid-stimulated chloride influx by bicycloorthocarboxylates, bicyclophosphorus esters, polychlorocycloalkanes and other cage convulsants.
The Journal of pharmacology and experimental therapeutics 1988;244(3):802-6.
1988: Bloom J W; Halonen M; Yamamura H I
Characterization of muscarinic cholinergic receptor subtypes in human peripheral lung.
The Journal of pharmacology and experimental therapeutics 1988;244(2):625-32.
1988: Lai J; Mei L; Roeske W R; Chung F Z; Yamamura H I; Venter J C
The cloned murine M1 muscarinic receptor is associated with the hydrolysis of phosphatidylinositols in transfected murine B82 cells.
Life sciences 1988;42(24):2489-502.
1988: Watson M; Roeske W R; Yamamura H I
Decreased muscarinic receptor density in the aged rat brain.
Proceedings of the Western Pharmacology Society 1988;31():61-5.
1988: Obata T; Morelli M; Concas A; Serra M; Yamamura H I
Modulation of GABA-stimulated chloride influx into membrane vesicles from rat cerebral cortex by benzodiazepines and nonbenzodiazepines.
Advances in biochemical psychopharmacology 1988;45():175-87.
1988: Hawkins K N; Knapp R J; Gehlert D R; Lui G K; Yamamura M S; Roeske L C; Hruby V J; Yamamura H I
Quantitative autoradiography of [3H]CTOP binding to mu opioid receptors in rat brain.
Life sciences 1988;42(25):2541-51.
1988: Obata T; Yamamura H I
Modulation of GABA-stimulated chloride influx into membrane vesicles from rat cerebral cortex by triazolobenzodiazepines.
Life sciences 1988;42(6):659-65.
1988: Malatynska E; Knapp R J; Ikeda M; Yamamura H I
Antidepressants and seizure-interactions at the GABA-receptor chloride-ionophore complex.
Life sciences 1988;43(4):303-7.
1987: Yamada S; Gehlert D R; Hawkins K N; Nakayama K; Roeske W R; Yamamura H I
Autoradiographic localization of nicotinic receptor binding in rat brain using [3H]methylcarbamylcholine, a novel radioligand.
Life sciences 1987;41(26):2851-61.
1987: Wang J X; Roeske W R; Gulya K; Wang W; Yamamura H I
[3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.
Life sciences 1987;41(14):1751-60.
1987: Smith T L; Yamamura H I
Competitive inhibition of phosphoinositide hydrolysis by the muscarinic receptor antagonist AF-DX 116 is of low affinity in mouse cerebral cortex.
Brain research 1987;420(2):362-4.
1987: Mei L; Wang J X; Roeske W R; Yamamura H I
Thermodynamic analyses of pirenzepine binding to membrane-bound and solubilized muscarinic receptors from rat forebrain and heart.
The Journal of pharmacology and experimental therapeutics 1987;242(3):991-1000.
1987: Wang J X; Mei L; Yamamura H I; Roeske W R
Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
The Journal of pharmacology and experimental therapeutics 1987;242(3):981-90.
1987: Nelson D L; Monroe P J; Lambert G; Yamamura H I
[3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
Life sciences 1987;41(13):1567-76.
1987: Wang J X; Yamamura H I; Wang W; Roeske W R
Differential regulation of M2 muscarinic receptors by guanine nucleotides in rat cerebral cortical and cardiac membranes.
European journal of pharmacology 1987;139(3):357-8.
1987: Bloom J W; Halonen M; Seaver N A; Yamamura H I
Heterogeneity of the M1 muscarinic receptor subtype between peripheral lung and cerebral cortex demonstrated by the selective antagonist AF-DX 116.
Life sciences 1987;41(4):491-6.
1987: Earle M E; Concas A; Wamsley J K; Yamamura H I
Temperature dependence and GABA modulation of [3H]triazolam binding in the rat brain.
Life sciences 1987;41(4):397-403.
1987: Berzetei I P; Yamamura H I; Duckles S P
Characterization of rabbit ear artery opioid receptors using a delta-selective agonist and antagonist.
European journal of pharmacology 1987;139(1):61-6.
1987: Fox D A; Ayres E A; Wire W S; Lui G; Yamamura H I; Burks T F
Kentsin: tetrapeptide from hamster embryos produces naloxone-sensitive effects without binding to opioid receptors.
Peptides 1987;8(4):613-8.
1987: Obata T; Yamamura H I
Inhibition of GABA-stimulated chloride influx by the convulsant benzodiazepines Ro 5-3663 and Ro 5-4864 into membrane vesicles from rat cerebral cortex.
European journal of pharmacology 1987;136(3):447-8.
1987: Duckles S P; Yamamura H I; Lee V
AF-DX 116 discriminates between muscarinic M2 receptors of the heart and vasculature.
Life sciences 1987;40(15):1507-11.
1987: Bloom J W; Halonen M; Lawrence L J; Rould E; Seaver N A; Yamamura H I
Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
The Journal of pharmacology and experimental therapeutics 1987;240(1):51-8.
1987: Bloom J W; Yamamura H I; Baumgartener C; Halonen M
A muscarinic receptor with high affinity for pirenzepine mediates vagally induced bronchoconstriction.
European journal of pharmacology 1987;133(1):21-7.
1987: Hawkins K N; Morelli M; Gulya K; Chang K J; Yamamura H I
Autoradiographic localization of [3H] [MePhe3,D-Pro4]morphiceptin ([3H]PL017) to mu opioid receptors in rat brain.
European journal of pharmacology 1987;133(3):351-2.
1987: Lemcke P K; Sugg E; Malarchik M; Lui G; Serra M; Yamamura H I; Hruby V J; Shook J E; Burks T F
N-terminal cyclization of a nonsulfated CCK analogue exhibits opioid antagonist activity in vitro.
Proceedings of the Western Pharmacology Society 1987;30():223-6.
1986: Smith T L; Yamamura H I; Lee L
Effect of ethanol on receptor-stimulated phosphatidic acid and polyphosphoinositide metabolism in mouse brain.
Life sciences 1986;39(18):1675-84.
1986: Pelton J T; Kazmierski W; Gulya K; Yamamura H I; Hruby V J
Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
Journal of medicinal chemistry 1986;29(11):2370-5.
1986: Obata T; Yamamura H I
The effect of benzodiazepines and beta-carbolines on GABA-stimulated chloride influx by membrane vesicles from the rat cerebral cortex.
Biochemical and biophysical research communications 1986;141(1):1-6.
1986: Sugg E E; Shook J E; Serra M; Korc M; Yamamura H I; Burks T F; Hruby V J
Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33.
Life sciences 1986;39(18):1623-9.
1986: Serra M; Smith T L; Yamamura H I
Phorbol esters alter muscarinic receptor binding and inhibit polyphosphoinositide breakdown in human neuroblastoma (SH-SY5Y) cells.
Biochemical and biophysical research communications 1986;140(1):160-6.
1986: Clark J A; Itzhak Y; Hruby V J; Yamamura H I; Pasternak G W
[D-Pen2,D-Pen5]enkephalin (DPDPE): a delta-selective enkephalin with low affinity for mu 1 opiate binding sites.
European journal of pharmacology 1986;128(3):303-4.
1986: Gee K W; Lawrence L J; Yamamura H I
Modulation of the chloride ionophore by benzodiazepine receptor ligands: influence of gamma-aminobutyric acid and ligand efficacy.
Molecular pharmacology 1986;30(3):218-25.
1986: Gulya K; Gehlert D R; Wamsley J K; Mosberg H; Hruby V J; Yamamura H I
Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
The Journal of pharmacology and experimental therapeutics 1986;238(2):720-6.
1986: Hynes M R; Banner W; Yamamura H I; Duckles S P
Characterization of muscarinic receptors of the rabbit ear artery smooth muscle and endothelium.
The Journal of pharmacology and experimental therapeutics 1986;238(1):100-5.
1986: Brinton R E; Gruener R; Deshmukh P; Yamamura H I
In vitro inhibition of vasopressin release in brain by behaviorally relevant ethanol concentrations.
Neuroscience letters 1986;67(2):213-7.
1986: Gulya K; Pelton J T; Hruby V J; Yamamura H I
Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors.
Life sciences 1986;38(24):2221-9.
1986: Watson M; Roeske W R; Yamamura H I
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
The Journal of pharmacology and experimental therapeutics 1986;237(2):419-27.
1986: Watson M; Yamamura H I; Roeske W R
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
The Journal of pharmacology and experimental therapeutics 1986;237(2):411-8.
1986: Yamada S; Yamamura H I; Roeske W R
Effects of chemical sympathectomy with 6-hydroxydopamine on alpha- and beta-adrenoceptors and muscarinic cholinoceptors in rat kidney.
European journal of pharmacology 1986;121(3):345-53.
1986: Akiyama K; Vickroy T W; Watson M; Roeske W R; Reisine T D; Smith T L; Yamamura H I
Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover.
The Journal of pharmacology and experimental therapeutics 1986;236(3):653-61.
1986: Brinton R E; Gehlert D R; Wamsley J K; Wan Y P; Yamamura H I
Vasopressin metabolite, AVP4-9, binding sites in brain: distribution distinct from that of parent peptide.
Life sciences 1986;38(5):443-52.
1986: Concas A; Gehlert D R; Wamsley J K; Yamamura H I
Effect of benzodiazepine binding site ligands on [35S] t-butylbicyclophosphorothionate ([35S]TBPS) binding to rat brain: an autoradiographic study.
Advances in biochemical psychopharmacology 1986;41():227-38.
1986: Gulya K; Lui G K; Pelton J T; Kazmierski W; Hruby V J; Yamamura H I
H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
NIDA research monograph 1986;75():209-12.
1985: Gehlert D R; Dawson T M; Yamamura H I; Wamsley J K
Quantitative autoradiography of [3H]forskolin binding sites in the rat brain.
Brain research 1985;361(1-2):351-60.
1985: Evans R A; Watson M; Yamamura H I; Roeske W R
Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
The Journal of pharmacology and experimental therapeutics 1985;235(3):612-8.
1985: Vickroy T W; Watson M; Leventer S M; Roeske W R; Hanin I; Yamamura H I
Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
The Journal of pharmacology and experimental therapeutics 1985;235(3):577-82.
1985: Wamsley J K; Golden J S; Yamamura H I; Barnett A
Autoradiographic demonstration of the selectivity of two 1-N-trifluoroethyl benzodiazepines for the BZD-1 receptors in the rat brain.
Pharmacology, biochemistry, and behavior 1985;23(6):973-8.
1985: Watson M; Vickroy T W; Fibiger H C; Roeske W R; Yamamura H I
Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
Brain research 1985;346(2):387-91.
1985: Gulya K; Wamsley J K; Gehlert D; Pelton J T; Duckles S P; Hruby V J; Yamamura H I
Light microscopic autoradiographic localization of somatostatin receptors in the rat brain.
The Journal of pharmacology and experimental therapeutics 1985;235(1):254-8.
1985: Lawrence L J; Palmer C J; Gee K W; Wang X; Yamamura H I; Casida J E
t-[3H]butylbicycloorthobenzoate: new radioligand probe for the gamma-aminobutyric acid-regulated chloride ionophore.
Journal of neurochemistry 1985;45(3):798-804.
1985: Lee H R; Watson M; Yamamura H I; Roeske W R
Decreased [3H]nitrendipine binding in the brainstem of deoxycorticosterone-NaCl hypertensive rats.
Life sciences 1985;37(10):971-7.
1985: Smith T L; Yamamura H I
Carbachol stimulation of phosphatidic acid synthesis: competitive inhibition by pirenzepine in synaptosomes from rat cerebral cortex.
Biochemical and biophysical research communications 1985;130(1):282-5.
1985: Lee H R; Jaros J A; Roeske W R; Wiech N L; Ursillo R; Yamamura H I
Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
The Journal of pharmacology and experimental therapeutics 1985;233(3):611-6.
1985: Gulya K; Gehlert D R; Wamsley J K; Mosberg H I; Hruby V J; Duckles S P; Yamamura H I
Autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
European journal of pharmacology 1985;111(2):285-6.
1985: Gehlert D R; Yamamura H I; Wamsley J K
gamma-Aminobutyric acidB receptors in the rat brain: quantitative autoradiographic localization using [3H](-)-baclofen.
Neuroscience letters 1985;56(2):183-8.
1985: Akiyama K; Gee K W; Mosberg H I; Hruby V J; Yamamura H I
Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
Proceedings of the National Academy of Sciences of the United States of America 1985;82(8):2543-7.
1985: Richter J A; Yamamura H I
Effects of pentobarbital on t-[35S]butylbicyclophosphorothionate and [3H]flunitrazepam binding to membrane-bound and solubilized preparations from rat forebrain.
The Journal of pharmacology and experimental therapeutics 1985;233(1):125-33.
1985: Vickroy T W; Roeske W R; Gehlert D R; Wamsley J K; Yamamura H I
Quantitative light microscopic autoradiography of [3H]hemicholinium-3 binding sites in the rat central nervous system: a novel biochemical marker for mapping the distribution of cholinergic nerve terminals.
Brain research 1985;329(1-2):368-73.
1985: Darman P S; Landis G C; Smits J R; Hirning L D; Gulya K; Yamamura H I; Burks T F; Hruby V J
Conformationally restricted cyclic analogues of substance P: insight into the receptor binding process.
Biochemical and biophysical research communications 1985;127(2):656-62.
1985: Brinton R E; Wamsley J K; Gehlert D; Wan Y P; Yamamura H I
Vasopressin metabolite peptide (AVP-(4-9)) binding sites in rat kidney: distribution distinct from vasopressin binding sites.
European journal of pharmacology 1985;108(3):321-2.
1985: Dawson T M; Gehlert D R; Yamamura H I; Barnett A; Wamsley J K
D-1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390.
European journal of pharmacology 1985;108(3):323-5.
1985: Gehlert D R; Yamamura H I; Wamsley J K
Autoradiographic localization of "peripheral-type" benzodiazepine binding sites in the rat brain, heart and kidney.
Naunyn-Schmiedeberg's archives of pharmacology 1985;328(4):454-60.
1985: Yamamura H I; Vickroy T W; Gehlert D R; Wamsley J K; Roeske W R
Autoradiographic localization of muscarinic agonist binding sites in the rat central nervous system with (+)-cis-[3H]methyldioxolane.
Brain research 1985;325(1-2):340-4.
1985: Pelton J T; Gulya K; Hruby V J; Duckles S P; Yamamura H I
Conformationally restricted analogs of somatostatin with high mu-opiate receptor specificity.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(1):236-9.
1985: Watson M; Vickroy T W; Roeske W R; Yamamura H I
Functional and biochemical basis for multiple muscarinic acetylcholine receptors.
Progress in neuro-psychopharmacology & biological psychiatry 1985;9(5-6):569-74.
1985: Yamamura H I; Gehlert D R; Gee K W; Wamsley J K; Horst W D; Roeske W R
Specific high-affinity [3H]Ro5-4864 Ro5-4864 benzodiazepine binding sites in the brain and periphery.
Progress in clinical and biological research 1985;192():187-96.
1985: Roeske W R; Lee H R; Yamamura H I; Schoemaker H
Identification of calcium-channel receptors in intact animals.
Advances in myocardiology 1985;6():71-82.
1985: Wamsley J K; Golden J S; Yamamura H I; Barnett A
Quazepam, a sedative-hypnotic selective for the benzodiazepine type 1 receptor: autoradiographic localization in rat and human brain.
Clinical neuropharmacology 1985;8 Suppl 1():S26-40.
1985: Pelton J T; Gulya K; Hruby V J; Duckles S; Yamamura H I
Somatostatin analogs with affinity for opiate receptors in rat brain binding assay.
Peptides 1985;6 Suppl 1():159-63.
1985: Lawrence L J; Gee K W; Yamamura H I
Interactions of pyrethroid insecticides with chloride ionophore-associated binding sites.
Neurotoxicology 1985;6(2):87-98.
1984: Vickroy T W; Roeske W R; Yamamura H I
Sodium-dependent high-affinity binding of [3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites.
Life sciences 1984;35(23):2335-43.
1984: Akiyama K; Yamamura H I; Wilkes B C; Cody W L; Hruby V J; Castrucci A M; Hadley M E
Relative stability of alpha-melanotropin and related analogues to rat brain homogenates.
Peptides 1984;5(6):1191-5.
1984: Brinton R E; Gee K W; Wamsley J K; Davis T P; Yamamura H I
Regional distribution of putative vasopressin receptors in rat brain and pituitary by quantitative autoradiography.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(22):7248-52.
1984: Gehlert D R; Dawson T M; Yamamura H I; Wamsley J K
Localization of [3H]forskolin binding sites in the rat brain using quantitative autoradiography.
European journal of pharmacology 1984;106(1):223-5.
1984: Vickroy T W; Watson M; Yamamura H I; Roeske W R
Agonist binding to multiple muscarinic receptors.
Federation proceedings 1984;43(13):2785-90.
1984: Gee K W; Yamamura S H; Roeske W R; Yamamura H I
Benzodiazepine receptor heterogeneity: possible molecular basis and functional significance.
Federation proceedings 1984;43(13):2767-72.
1984: Lawrence L J; Gee K W; Yamamura H I
Benzodiazepine anticonvulsant action: gamma-aminobutyric acid-dependent modulation of the chloride ionophore.
Biochemical and biophysical research communications 1984;123(3):1130-7.
1984: Yamamura H I; Watson M; Wamsley J K; Johnson P C; Roeske W R
Light microscopic autoradiographic localization of [3H]pirenzepine and [3H](-)quinuclidinyl benzilate binding in human stellate ganglia.
Life sciences 1984;35(7):753-7.
1984: Lee H R; Roeske W R; Yamamura H I
High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Life sciences 1984;35(7):721-32.
1984: Vickroy T W; Fibiger H C; Roeske W R; Yamamura H I
Reduced density of sodium-dependent [3H]hemicholinium-3 binding sites in the anterior cerebral cortex of rats following chemical destruction of the nucleus basalis magnocellularis.
European journal of pharmacology 1984;102(2):369-70.
1984: Brinton R E; Wamsley J K; Gee K W; Wan Y P; Yamamura H I
[3H]oxytocin binding sites in the rat brain demonstrated by quantitative light microscopic autoradiography.
European journal of pharmacology 1984;102(2):365-7.
1984: Ehlert F J; Yamamura H I
A comparison of the effects of cinnarizine and related compounds on [3H]nitrendipine binding in the brain, heart and ileum.
Life sciences 1984;34(24):2347-55.
1984: Vickroy T W; Roeske W R; Yamamura H I
Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
The Journal of pharmacology and experimental therapeutics 1984;229(3):747-55.
1984: Boles R G; Yamamura H I; Schoemaker H; Roeske W R
Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
The Journal of pharmacology and experimental therapeutics 1984;229(2):333-9.
1984: Wamsley J K; Gehlert D R; Roeske W R; Yamamura H I
Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepine.
Life sciences 1984;34(14):1395-402.
1984: Maurin Y; Buck S H; Wamsley J K; Burks T F; Yamamura H I
Light microscopic autoradiographic localization of [3H] substance P binding sites in rat thoracic spinal cord.
Life sciences 1984;34(18):1713-6.
1984: Wilkes B C; Hruby V J; Yamamura H I; Akiyama K; Castrucci A M; Hadley M E; Andrews J R; Wan Y P
Synthesis of tritium labeled Ac-[Nle4, D-Phe7]-alpha-MSH4-11-NH2: a superpotent melanotropin with prolonged biological activity.
Life sciences 1984;34(10):977-84.
1984: Akiyama K; Watson M; Roeske W R; Yamamura H I
High-affinity [3H]pirenzepine binding to putative M1 muscarinic sites in the neuroblastoma x glioma hybrid cell line (NG 108-15).
Biochemical and biophysical research communications 1984;119(1):289-97.
1984: Watson M; Roeske W R; Johnson P C; Yamamura H I
[3H]Pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia.
Brain research 1984;290(1):179-82.
1984: Buck S H; Maurin Y; Burks T F; Yamamura H I
High-affinity 3H-substance P binding to longitudinal muscle membranes of the guinea pig small intestine.
Life sciences 1984;34(5):497-507.
1984: Vickroy T W; Watson M; Yamamura H I; Roeske W R
Differential regulation of putative M1/M2 muscarinic receptors: implications for different receptor-effector coupling mechanisms.
Advances in experimental medicine and biology 1984;175():99-114.
1984: Gehlert D R; Yamamura H I; Wamsley J K
Use of autoradiographic techniques for the localization of neurotransmitter receptors in brain and periphery: recent applications.
Advances in experimental medicine and biology 1984;175():255-70.
1984: Mimaki T; Yabuuchi H; Laird H; Yamamura H I
Effects of seizures and antiepileptic drugs on benzodiazepine receptors in rat brain.
Pediatric pharmacology (New York, N.Y.) 1984;4(4):205-11.
1983: Deshmukh P P; Yamamura H I; Woods L; Nelson D L
Computer-assisted autoradiographic localization of subtypes of serotonin1 receptors in rat brain.
Brain research 1983;288(1-2):338-43.
1983: Wamsley J K; Gee K W; Yamamura H I
Comparison of the distribution of convulsant/barbiturate and benzodiazepine receptors using light microscopic autoradiography.
Life sciences 1983;33(23):2321-9.
1983: Erman R D; Yamamura H I; Roeske W R
The ontogeny of specific binding sites for the calcium channel antagonist, nitrendipine, in mouse heart and brain.
Brain research 1983;278(1-2):327-31.
1983: Gehlert D R; Yamamura H I; Wamsley J K
Autoradiographic localization of 'peripheral' benzodiazepine binding sites in the rat brain and kidney using [3H]RO5-4864.
European journal of pharmacology 1983;95(3-4):329-30.
1983: Gee K W; Yamamura H I
Photoaffinity labeling of benzodiazepine receptors in rat brain with flunitrazepam alters the affinity of benzodiazepine receptor agonist but not antagonist binding.
Journal of neurochemistry 1983;41(5):1407-13.
1983: Lee H R; Roeske W R; Yamamura H I
The measurement of free nitrendipine in human serum by an equilibrium dialysis - radioreceptor assay.
Life sciences 1983;33(18):1821-9.
1983: Vickroy T W; Yamamura H I; Roeske W R
Differential regulation of high-affinity agonist binding to muscarinic sites in the rat heart, cerebellum, and cerebral cortex.
Biochemical and biophysical research communications 1983;116(1):284-90.
1983: Smith T L; Vickers A E; Brendel K; Yamamura H I
Influence of chronic ethanol treatment on alpha1-adrenergic and vasopressin receptor-stimulated phosphatidylinositol synthesis in isolated rat hepatocytes.
Biochemical pharmacology 1983;32(20):3059-62.
1983: Mosberg H I; Hurst R; Hruby V J; Gee K; Yamamura H I; Galligan J J; Burks T F
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(19):5871-4.
1983: Buck S H; Walsh J H; Davis T P; Brown M R; Yamamura H I; Burks T F
Characterization of the peptide and sensory neurotoxic effects of capsaicin in the guinea pig.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1983;3(10):2064-74.
1983: Ehlert F J; Roeske W R; Gee K W; Yamamura H I
An allosteric model for benzodiazepine receptor function.
Biochemical pharmacology 1983;32(16):2375-83.
1983: Yamamura H I; Wamsley J K; Deshmukh P; Roeske W R
Differential light microscopic autoradiographic localization of muscarinic cholinergic receptors in the brainstem and spinal cord of the rat using [3H]pirenzepine.
European journal of pharmacology 1983;91(1):147-9.
1983: Watson M; Yamamura H I; Roeske W R
A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
Life sciences 1983;32(26):3001-11.
1983: Brinton R E; Deshmukh P P; Chen A; Davis T P; Hsiao S; Yamamura H I
A non-equilibrium 24-hour vasopressin radioimmunoassay: development and basal levels in the rat brain.
Brain research 1983;266(2):344-7.
1983: Gee K W; Wamsley J K; Yamamura H I
Light microscopic autoradiographic identification of picrotoxin/barbiturate binding sites in rat brain with [35S]t-butyl-bicyclophosphothionate.
European journal of pharmacology 1983;89(3-4):323-4.
1983: Mosberg H I; Hurst R; Hruby V J; Galligan J J; Burks T F; Gee K; Yamamura H I
Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivity.
Life sciences 1983;32(22):2565-9.
1983: Yamamura H I; Gee K W; Brinton R E; Davis T P; Hadley M; Wamsley J K
Light microscopic autoradiographic visualization of [3H]-arginine vasopressin binding sites in rat brain.
Life sciences 1983;32(16):1919-24.
1983: Gee K W; Ehlert F J; Yamamura H I
Differential effect of gamma-aminobutyric acid on benzodiazepine receptor subtypes labeled by [3H]propyl beta-carboline-3-carboxylate in rat brain.
The Journal of pharmacology and experimental therapeutics 1983;225(1):132-7.
1983: Schoemaker H; Boles R G; Horst W D; Yamamura H I
Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney.
The Journal of pharmacology and experimental therapeutics 1983;225(1):61-9.
1983: Schoemaker H; Lee H R; Roeske W R; Yamamura H I
In vivo identification of calcium antagonist binding sites using [3H]nitrendipine.
European journal of pharmacology 1983;88(2-3):275-6.
1983: Gee K W; Brinton R E; Yamamura H I
PK 8165 and PK 9084, two quinoline derivatives with anxiolytic properties, antagonize the anticonvulsant effects of diazepam.
Brain research 1983;264(1):168-72.
1983: Gee K W; Brinton R E; Yamamura H I
CL 218872 antagonism of diazepam induced loss of righting reflex: evidence for partial agonistic activity at the benzodiazepine receptor.
Life sciences 1983;32(9):1037-40.
1983: Schoemaker H; Smith T L; Yamamura H I
Effect of chronic ethanol consumption on central and peripheral type benzodiazepine binding sites in the mouse brain.
Brain research 1983;258(2):347-50.
1983: Bonhaus D W; Laird H; Mimaki T; Yamamura H I; Huxtable R J
Possible bases for the anticonvulsant action of taurine.
Progress in clinical and biological research 1983;125():195-209.
1983: Yamamura H I; Watson M; Roeske W R
[3H]pirenzepine specifically labels a high affinity muscarinic receptor in the rat cerebral cortex.
Advances in biochemical psychopharmacology 1983;37():331-6.
1983: Roeske W R; Ehlert F J; Barritt D S; Yamanaka K; Rosenberger L B; Yamada S; Yamamura S; Yamamura H I
Recent advances in muscarinic receptor heterogeneity and regulation.
Advances in biochemical psychopharmacology 1983;36():15-30.
1983: Mosberg H I; Hurst R; Hruby V J; Gee K; Akiyama K; Yamamura H I; Galligan J J; Burks T F
Cyclic penicillamine containing enkephalin analogs display profound delta receptor selectivities.
Life sciences 1983;33 Suppl 1():447-50.
1983: Davis T P; Schoemaker H; Culling A J; Yamamura H I
Isolation and characterization of in vitro central beta-endorphin metabolism in schizophrenia.
Proceedings of the Western Pharmacology Society 1983;26():89-94.
1983: Chen A D; Davis T P; Yamamura H I
Demonstration and partial characterization of a bovine cerebral cortical factor which interacts competitively at the benzodiazepine receptor.
Proceedings of the Western Pharmacology Society 1983;26():225-30.
1983: Schoemaker H; Boles R G; Roeske W R; Yamamura H I
Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
Proceedings of the Western Pharmacology Society 1983;26():219-24.
1983: Yamada S; Hayashi E; Yamamura H I; Roeske W R
Presynaptic muscarinic cholinergic and postsynaptic beta-adrenergic receptors in splenic tissue.
Advances in biochemical psychopharmacology 1983;36():43-51.
1983: Ehlert F J; Roeske W R; Yamamura S H; Yamamura H I
The benzodiazepine receptor: complex binding properties and the influence of GABA.
Advances in biochemical psychopharmacology 1983;36():209-20.
1983: Hynes M R; Culling A J; Galligan J J; Burks T F; Schoemaker H; Yamamura H I; Davis T P
Processing of beta-endorphin in the dog intestine: regional specificity.
Proceedings of the Western Pharmacology Society 1983;26():95-9.
1983: Gee K W; Yamamura H I
Selective anxiolytics: are the actions related to partial "agonist" activity or a preferential affinity for benzodiazepine receptor subtypes?
Advances in biochemical psychopharmacology 1983;38():1-9.
1982: Watson M; Roeske W R; Yamamura H I
[3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex.
Life sciences 1982;31(18):2019-23.
1982: Gee K W; Yamamura H I
Regional heterogeneity of benzodiazepine receptors at 37 degrees C: an in vitro study in various regions of the rat brain.
Life sciences 1982;31(18):1939-45.
1982: Schoemaker H; Chen A; Davis T P; Yamamura H I
A study of the metabolism of des-tyrosine-gamma-endorphin using an improved HPLC system.
Psychopharmacology bulletin 1982;18(4):144-8.
1982: Miller M S; Buck S H; Sipes I G; Yamamura H I; Burks T F
Regulation of substance P by nerve growth factor: disruption by capsaicin.
Brain research 1982;250(1):193-6.
1982: Yamamura H I; Schoemaker H; Boles R G; Roeske W R
Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes.
Biochemical and biophysical research communications 1982;108(2):640-6.
1982: Yamada S; Yamamura H I; Roeske W R
Characterization of postsynaptic beta-adrenergic receptors and presynaptic muscarinic cholinergic receptors in the rat spleen.
Life sciences 1982;31(11):1161-70.
1982: Schoemaker H; Morelli M; Deshmukh P; Yamamura H I
[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia.
Brain research 1982;248(2):396-401.
1982: Gee K W; Yamamura H I
Differentiation of benzodiazepine receptor agonist and antagonist: sparing of [3H]benzodiazepine antagonist binding following the photolabelling of benzodiazepine receptors.
European journal of pharmacology 1982;82(3-4):239-41.
1982: Yamada S; Yamamura H I; Roeske W R
An increase in cardiac alpha 1-adrenoceptors following chronic clonidine treatment.
Naunyn-Schmiedeberg's archives of pharmacology 1982;320(2):115-8.
1982: Ehlert F J; Roeske W R; Yamamura H I
A simple and rapid radio-receptor assay for the estimation of acetylcholine.
Life sciences 1982;31(4):347-54.
1982: Morelli M; Gee K W; Yamamura H I
The effect of GABA on in vitro binding of two novel non-benzodiazepines, PK 8165 and CGS 8216, to benzodiazepine receptors in the rat brain.
Life sciences 1982;31(1):77-81.
1982: Chen F C; Yamamura H I; Roeske W R
Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
The Journal of pharmacology and experimental therapeutics 1982;222(1):7-13.
1982: Schoemaker H; Davis T P; Pedigo N W; Chen A; Berens E S; Ragan P; Ling N C; Yamamura H I
Identification of beta-endorphin-6(16-17) as the principal metabolite of des-tyrosin-gamma-endorphin (DTgammaE) in vitro and assessment of its activity in neurotransmitter receptor binding assays.
European journal of pharmacology 1982;81(3):459-68.
1982: Ehlert F J; Roeske W R; Itoga E; Yamamura H I
The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
Life sciences 1982;30(25):2191-202.
1982: Gee K W; Ehlert F J; Yamamura H I
The influence of temperature and gamma-aminobutyric acid on benzodiazepine receptor subtypes in the hippocampus of the rat.
Biochemical and biophysical research communications 1982;106(4):1134-40.
1982: Gee K W; Yamamura H I
A novel pyrazoloquinoline that interacts with brain benzodiazepine receptors: characterization of some in vitro and in vivo properties of CGS 9896.
Life sciences 1982;30(26):2245-52.
1982: Mosberg H I; Hurst R; Hruby V J; Galligan J J; Burks T F; Gee K; Yamamura H I
[D-Pen2, L-Cys5]enkephalinamide and[D-Pen2, D-Cys5] enkephalinamide, conformationally constrained cyclic enkephalinamide analogs with delta receptor specificity.
Biochemical and biophysical research communications 1982;106(2):506-12.
1982: Buck S H; Walsh J H; Yamamura H I; Burks T F
Neuropeptides in sensory neurons.
Life sciences 1982;30(22):1857-66.
1982: Gee K W; Morelli M; Yamamura H I
The effect of temperature on CL 218872 and propyl beta-carboline-3-carboxylate inhibition of [3H]-flunitrazepam binding in rat brain.
Biochemical and biophysical research communications 1982;105(4):1532-7.
1982: Barritt D; Yamamura H I; Roeske W R
Muscarinic receptor binding in the mouse heart: the selective modulatory effect of fluoride ion on agonist binding.
Life sciences 1982;30(10):875-7.
1982: Davis T P; Schoemaker H; Chen A; Yamamura H I
High performance liquid chromatography of pharmacologically active amines and peptides in biological materials.
Life sciences 1982;30(12):971-87.
1982: Gee K W; Horst W D; O'Brien R; Yamamura H I
High affinity inhibition of [3H]-flunitrazepam binding to brain benzodiazepine receptors by CGS 9896, a novel pyrazoloquinoline.
Biochemical and biophysical research communications 1982;105(2):457-61.
1982: Ehlert F J; Itoga E; Roeske W R; Yamamura H I
The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats.
Biochemical and biophysical research communications 1982;104(3):937-43.
1982: Ehlert F J; Ragan P; Chen A; Roeske W R; Yamamura H I
Modulation of benzodiazepine receptor binding: insight into pharmacological efficacy.
European journal of pharmacology 1982;78(2):249-53.
1982: Yamamura H I; Mimaki T; Yamamura S H; Horst W D; Morelli M; Bautz G; O'Brien R A
[3H]CL 218,872, a novel triazolopyridazine which labels the benzodiazepine receptors in rat brain.
European journal of pharmacology 1982;77(4):351-4.
1982: Deshmukh P P; Nelson D L; Yamamura H I
Autoradiographic localization of 5-HT1 receptor subtypes in rat brain.
Proceedings of the Western Pharmacology Society 1982;25():83-6.
1982: Brinton R E; Buck S H; Deshmukh P P; Hsiao S; Yamamura H I
Radioimmunoassay of vasopressin: development and application to the measurement of intra- and extra-hypothalamic vasopressin levels in the rat.
Proceedings of the Western Pharmacology Society 1982;25():73-4.
1982: Ehlert F J; Roeske W R; Yamamura H I
A radioreceptor assay for estimation of acetylcholine.
Proceedings of the Western Pharmacology Society 1982;25():237-9.
1982: Davis T P; Schoemaker H; Chen A; Culling A; Yamamura H I
Isolation and characterization of in vitro endorphin metabolism in the brain.
Proceedings of the Western Pharmacology Society 1982;25():101-5.
1982: Morelli M; DiChiara G; Yamamura H I
The role of the dorsal mesencephalic reticular formation and deep layers of the superior colliculus in the turning behavior originating from the corpus striatum.
Proceedings of the Western Pharmacology Society 1982;25():433-6.
1982: Reisine T; Johnson R; Wiech N; Ursillo R; Yamamura H I
Rapid desensitization of central beta-receptors and up-regulation of alpha 2-receptors following antidepressant treatment.
Advances in biochemical psychopharmacology 1982;31():63-7.
1982: Buck S H; Burks T F; Yamamura H I
Neuropeptide alterations in the central nervous system in aging.
Gerontology 1982;28 Suppl 1():25-34.
1982: Buck S H; Yamamura H I
Neuropeptides in normal and pathological basal ganglia.
Advances in neurology 1982;35():121-32.
1982: Buck S H; Miller M S; Deshmukh P P; Yamamura H I; Burks T F
Peptides in sensory nerves.
Proceedings of the Western Pharmacology Society 1982;25():211-6.
1981: Regan J W; Roeske W R; Malick J B; Yamamura S H; Yamamura H I
gamma-Aminobutyric acid enhancement of CL 218,872 affinity and evidence of benzodiazepine receptor heterogeneity.
Molecular pharmacology 1981;20(3):477-83.
1981: Mimaki T; Yamamura H I
Modulation of benzodiazepine receptor binding by antiepileptic drugs and seizures.
Medical journal of Osaka University 1981;32(1-2):15-24.
1981: Regan J W; Roeske W R; Ruth W H; Deshmukh P; Yamamura H I
Reductions in retinal gamma-aminobutyric acid (GABA) content and in [3H]flunitrazepam binding after postnatal monosodium glutamate injections in rats.
The Journal of pharmacology and experimental therapeutics 1981;218(3):791-6.
1981: Ehlert F J; Roeske W R; Yamamura H I
Multiple benzodiazepine receptors and their regulation by gamma-aminobutyric acid.
Life sciences 1981;29(3):235-48.
1981: Ehlert F J; Roeske W R; Yamamura H I
Striatal muscarinic receptors: regulation by dopaminergic agonists.
Life sciences 1981;28(21):2441-8.
1981: Ehlert F J; Roeske W R; Yamamura H I
Mathematical analysis of the kinetics of competitive inhibition in neurotransmitter receptor binding assays.
Molecular pharmacology 1981;19(3):367-71.
1981: Schoemaker H; Bliss M; Yamamura H I
Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex.
European journal of pharmacology 1981;71(1):173-5.
1981: Ehlert F J; Roeske W R; Braestrup C; Yamamura S H; Yamamura H I
gamma-Aminobutyric acid regulation of the benzodiazepine receptor: biochemical evidence for pharmacologically different effects of benzodiazepines and propyl beta-carboline-3-carboxylate.
European journal of pharmacology 1981;70(4):593-5.
1981: Buck S H; Burks T F; Brown M R; Yamamura H I
Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
Brain research 1981;209(2):464-9.
1981: Regan J W; Yamamura H I; Yamada S; Roeske W R
High affinity [3H]flunitrazepam binding: characterization, localization, and alteration in hypertension.
Life sciences 1981;28(9):991-8.
1981: Ehlert F J; Roeske W R; Yamamura H I
Muscarinic receptor: regulation by guanine nucleotides, ions, and N-ethylmaleimide.
Federation proceedings 1981;40(2):153-9.
1981: London E D; Yamamura H I; Bird E D; Coyle J T
Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
Biological psychiatry 1981;16(2):155-62.
1981: Pedigo N W; Yamamura H I; Nelson D L
Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.
Journal of neurochemistry 1981;36(1):220-6.
1981: Nelson D L; Pedigo N W; Yamamura H I
Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
Journal de physiologie 1981;77(2-3):369-72.
1981: Ehlert F J; Roeske W R; Yamamura H I
Dopaminergic regulation of muscarinic receptor binding in the corpus striatum.
Proceedings of the Western Pharmacology Society 1981;24():93-5.
1981: Overstreet D H; Driscoll P; Martin J R; Yamamura H I
Brain muscarinic cholinergic receptor binding in Roman high- and low-avoidance rats.
Psychopharmacology 1981;72(2):143-5.
1981: Pedigo N W; Schoemaker H; Morelli M; McDougal J N; Malick J B; Burks T F; Yamamura H I
Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney.
Neurobiology of aging 1981;2(2):83-8.
1981: Buck S H; Deshmukh P P; Burks T F; Yamamura H I
A survey of substance P, somatostatin, and neurotensin levels in aging in the rat and human central nervous system.
Neurobiology of aging 1981;2(4):257-64.
1981: Buck S H; Deshmukh P P; Yamamura H I; Burks T F
Thermal analgesia and substance P depletion induced by capsaicin in guinea-pigs.
Neuroscience 1981;6(11):2217-22.
1981: Burks T F; Buck S H; Miller M S; Deshmukh P P; Yamamura H I
Characterization in guinea pigs of the sensory effects of the putative substance P neurotoxin capsaicin.
Proceedings of the Western Pharmacology Society 1981;24():353-7.
1981: Lippa A S; Critchett D J; Ehlert F; Yamamura H I; Enna S J; Bartus R T
Age-related alterations in neurotransmitter receptors: an electrophysiological and biochemical analysis.
Neurobiology of aging 1981;2(1):3-8.
1981: Speth R C; Bresolin N; Mimaki T; Deshmukh P P; Yamamura H I
Neuronal localization of benzodiazepine receptors in the murine cerebellum.
Advances in biochemical psychopharmacology 1981;26():27-39.
1980: Yamada S; Yamamura H I; Roeske W R
Alterations in central and peripheral adrenergic receptors in deoxycorticosterone/salt hypertensive rats.
Life sciences 1980;27(24):2405-16.
1980: Mimaki T; Deshmukh P P; Yamamura H I
Decreased benzodiazepine receptor density in rat cerebellum following neurotoxic doses of phenytoin.
Journal of neurochemistry 1980;35(6):1473-5.
1980: Yamada S; Yamamura H I; Roeske W R
Ontogeny of mammalian cardiac alpha 1-adrenergic receptors.
European journal of pharmacology 1980;68(2):217-21.
1980: Regan J W; Yamamura H I; Yamada S; Roeske W R
Renal benzodiazepine binding increases during deoxycorticosterone/salt hypertension in rats.
European journal of pharmacology 1980;67(1):167-8.
1980: Speth R C; Johnson R W; Regan J; Reisine T; Kobayashi R M; Bresolin N; Roeske W R; Yamamura H I
The benzodiazepine receptor of mammalian brain.
Federation proceedings 1980;39(12):3032-8.
1980: Johnson R W; Reisine T; Spotnitz S; Wiech N; Ursillo R; Yamamura H I
Effects of desipramine and yohimbine on alpha 2- and beta-adrenoreceptor sensitivity.
European journal of pharmacology 1980;67(1):123-7.
1980: Yamada S; Yamamura H I; Roeske W R
Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment.
The Journal of pharmacology and experimental therapeutics 1980;215(1):176-85.
1980: Reisine T D; Overstreet D; Gale K; Rossor M; Iversen L; Yamamura H I
Benzodiazepine receptors: the effect of GABA on their characteristics in human brain and their alteration in Huntington's disease.
Brain research 1980;199(1):79-88.
1980: Smit M H; Ehlert F J; Yamamura S; Roeske W R; Yamamura H I
Differential regulation of muscarinic agonist binding sites following chronic cholinesterase inhibition.
European journal of pharmacology 1980;66(4):379-80.
1980: Yamada S; Yamamura H I; Roeske W R
Alterations in cardiac autonomic receptors following 6-hydroxydopamine treatment in rats.
Molecular pharmacology 1980;18(2):185-92.
1980: Olsen R W; Reisine T D; Yamamura H I
Neurotransmitter receptors-biochemistry and alterations in nueropsychiatric disorders.
Life sciences 1980;27(10):801-8.
1980: Schallert T; Overstreet D H; Yamamura H I
Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
Pharmacology, biochemistry, and behavior 1980;13(2):187-92.
1980: Martin A R; Paradkar V M; Peng G W; Speth R C; Yamamura H I; Horn A S
Conformationally restricted tricyclic antidepressants. 1. Octahydrodibenzazepinonaphthyridines as rigid imipramine analogues.
Journal of medicinal chemistry 1980;23(8):865-73.
1980: Martin A R; Kim S H; Yamamura H I; Horn A S
Conformationally restricted phenothiazine neuroleptics. 1. 3-(Dimethylamino)-1,2,3,4-tetrahydroazepino[3,2,1-kl]phenothiazine.
Journal of medicinal chemistry 1980;23(8):938-41.
1980: Overstreet D H; Speth R C; Hruska R E; Ehlert F; Dumont Y; Yamamura H I
Failure of septal lesions to alter muscarinic cholinergic or benzodiazepine binding sites in hippocampus of rat brain.
Brain research 1980;195(1):203-7.
1980: Rosenberger L B; Yamamura H I; Roeske W R
The regulation of cardiac muscarinic cholinergic receptors by isoproterenol.
European journal of pharmacology 1980;65(1):129-30.
1980: Meiners B A; Speth R C; Bresolin N; Huxtable R J; Yamamura H I
Sodium-dependent, high-affinity taurine transport into rat brain synaptosomes.
Federation proceedings 1980;39(9):2695-700.
1980: Yamada S; Yamamura H I; Roeske W R
The regulation of cardiac alpha 1-adrenergic receptors by guanine nucleotides and by muscarinic cholinergic agonists.
European journal of pharmacology 1980;63(2-3):239-41.
1980: Reisine T D; U'Prichard D C; Wiech N L; Ursillo R C; Yamamura H I
Effects of combined administration of amphetamine and iprindole on brain adrenergic receptors.
Brain research 1980;188(2):587-92.
1980: U'Prichard D C; Reisine T D; Mason S T; Fibiger H C; Yamamura H I
Modulation of rat brain alpha- and beta-adrenergic receptor populations by lesion of the dorsal noradrenergic bundle.
Brain research 1980;187(1):143-54.
1980: Regan J W; Roeske W R; Yamamura H I
3H-Flunitrazepam binding to bovine retina and the effect of GABA thereon.
Neuropharmacology 1980;19(4):413-4.
1980: Ehlert F J; Dumont Y; Roeske W R; Yamamura H I
Muscarinic receptor binding in rat brain using the agonist, [3H]cis methyldioxolane.
Life sciences 1980;26(12):961-7.
1980: Nagy J I; Vincent S R; Staines W A; Fibiger H C; Reisine T D; Yamamura H I
Neurotoxic action of capsaicin on spinal substance P neurons.
Brain research 1980;186(2):435-44.
1980: Ehlert F J; Yamamura H I; Triggle D J; Roeske W R
The influence of guanyl-5'-yl imidodiphosphate and sodium chloride on the binding of the muscarinic agonist, [3H] cis methyldioxolane.
European journal of pharmacology 1980;61(3):317-8.
1980: Rosenberger L B; Yamamura H I; Roeske W R
Cardiac muscarinic cholinergic receptor binding is regulated by Na+ and guanyl nucleotides.
The Journal of biological chemistry 1980;255(3):820-3.
1980: U'Prichard D C; Reisine T D; Yamamura S; Mason S T; Fibiger H C; Ehlert F; Yamamura H I
Differential supersensitivity of beta-receptor subtypes in rat cortex and cerebellum after central noradrenergic denervation.
Life sciences 1980;26(5):355-64.
1980: Ehlert F J; Roeske W R; Rosenberger L B; Yamamura H I
The influence of guanyl-5'-yl imidodiphosphate and sodium on muscarinic receptor binding in the rat brain and longitudinal muscle of the rat ileum.
Life sciences 1980;26(3):245-52.
1980: Regan J W; Roeske W R; Yamamura H I
The benzodiazepine receptor: its development and its modulation by gamma-aminobutyric acid.
The Journal of pharmacology and experimental therapeutics 1980;212(1):137-43.
1980: Houck J C; Kimball C; Chang C; Pedigo N W; Yamamura H I
Placental beta-endorphin-like peptides.
Science (New York, N.Y.) 1980;207(4426):78-80.
1980: Ehlert F J; Roeske W R; Yamamura H I
Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide.
Journal of supramolecular structure 1980;14(2):149-62.
1980: Reisine T D; Rossor M; Spokes E; Iversen L L; Yamamura H I
Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.
Advances in biochemical psychopharmacology 1980;21():443-50.
1980: Pedigo N W; Reisine T D; Schallert T; Overstreet D H; Ling N C; Ragan P; Yamamura H I
Possible role of opiate receptors and des-tyrosine1-gamma-endorphin in schizophrenia.
Advances in biochemical psychopharmacology 1980;22():549-62.
1980: U'Prichard D C; Yamamura H I; Reisine T D
Characterization and differential in vivo regulation of brain adrenergic receptor subtypes.
Advances in biochemical psychopharmacology 1980;21():213-21.
1979: Pedigo N W; Schallert T; Overstreet D H; Ling N C; Ragan P; Reisine T D; Yamamura H I
Inhibition of in vivo 3H-spiperone binding by the proposed antipsychotic Des-Tyr1-gamma-endorphin.
European journal of pharmacology 1979;60(4):359-64.
1979: Reisine T D; Nagy J I; Beaumont K; Fibiger H C; Yamamura H I
The localization of receptor binding sites in the substantia nigra and striatum of the rat.
Brain research 1979;177(2):241-52.
1979: Overstreet D H; Yamamura H I
Receptor alterations and drug tolerance.
Life sciences 1979;25(22):1865-77.
1979: Johnson R W; Yamamura H I
Photoaffinity labeling of the benzodiazepine receptor in bovine cerebral cortex.
Life sciences 1979;25(18):1613-20.
1979: Speth R C; Bresolin N; Yamamura H I
Acute diazepam administration produces rapid increases in brain benzodiazepine receptor density.
European journal of pharmacology 1979;59(1-2):159-60.
1979: Chen F M; Yamamura H I; Roeske W R
Ontogeny of mammalian myocardial beta-adrenergic receptors.
European journal of pharmacology 1979;58(3):255-64.
1979: Speth R C; Yamamura H I
On the ability of choline and its analogues to interact with muscarinic cholinergic receptors in the rat brain.
European journal of pharmacology 1979;58(2):197-201.
1979: Reisine T D; Rossor M; Spokes E; Iversen L L; Yamamura H I
Alterations in brain opiate receptors in Parkinson's disease.
Brain research 1979;173(2):378-82.
1979: Speth R C; Wastek G J; Reisine T D; Yamamura H I
Benzodiazepine receptors: effect of tissue preincubation at 37 degrees C.
Neuroscience letters 1979;13(3):243-7.
1979: Rosenberger L B; Roeske W R; Yamamura H I
The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue.
European journal of pharmacology 1979;56(1-2):179-80.
1979: Reisine T D; Nagy J I; Fibiger H C; Yamamura H I
Localization of dopamine receptors in rat brain.
Brain research 1979;169(1):209-14.
1979: Reisine T D; Azari J; Johnson P C; Barbeau A; Huxtable R; Yamamura H I
Brain neurotransmitter receptors in Friedreich's ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1979;6(2):259-62.
1979: Azari J; Reisine T; Barbeau A; Yamamura H I; Huxtable R
The Syrian golden hamster: a model for the cardiomyopathy of Friedreich's ataxia.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1979;6(2):223-6.
1979: Pedigo N W; Ling N C; Reisine T D; Yamamura H I
Examination of des-tyrosine1-gamma-endorphin activity at oH-spiroperidol binding sites in rat brain.
Life sciences 1979;24(18):1645-9.
1979: Reisine T D; Wastek G J; Speth R C; Bird E D; Yamamura H I
Alterations in the benzodiazepine receptor of Huntington's diseased human brain.
Brain research 1979;165(1):183-7.
1979: Speth R C; Yamamura H I
Benzodiazepine receptors: alterations in mutant mouse cerebellum.
European journal of pharmacology 1979;54(4):397-9.
1979: Beaumont K; Maurin Y; Reisine T D; Fields J Z; Spokes E; Bird E D; Yamamura H I
Huntington's disease and its animal model: alterations in kainic acid binding.
Life sciences 1979;24(9):809-16.
1979: Speth R C; Wastek G J; Yamamura H I
Benzodiazepine receptors: temperature dependence of [3H]flunitrazepam binding.
Life sciences 1979;24(4):351-7.
1979: Bresolin N; Speth R C; McManus T T; Yamamura H I; Stern L Z
Benzodiazepine receptors in animal models of cerebellar degeneration.
Transactions of the American Neurological Association 1979;104():198-200.
1978: Reisine T D; Yamamura H I; Bird E D; Spokes E; Enna S J
Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.
Brain research 1978;159(2):477-81.
1978: Kobayashi R M; Palkovits M; Hruska R E; Rothschild R; Yamamura H I
Regional distribution of muscarinic cholinergic receptors in rat brain.
Brain research 1978;154(1):13-23.
1978: Davis K L; Yamamura H I
Cholinergic underactivity in human memory disorders.
Life sciences 1978;23(17-18):1729-33.
1978: Hruska R E; Schwarcz R; Coyle J T; Yamamura H I
Alterations of muscarinic cholinergic receptors in the rat striatum after kainic acid injections.
Brain research 1978;152(3):620-5.
1978: Wastek G J; Yamamura H I
Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
Molecular pharmacology 1978;14(5):768-80.
1978: Pedigo N W; Reisine T D; Fields J Z; Yamamura H I
3H-Spiroperidol binding to two receptor sites in both the corpus striatum and frontal cortex of rat brain.
European journal of pharmacology 1978;50(4):451-3.
1978: Fields J Z; Reisine T D; Yamamura H I
Loss of striatal dopaminergic receptors after intrastriatal kainic acid injection.
Life sciences 1978;23(6):569-73.
1978: Wastek G J; Speth R C; Reisine T D; Yamamura H I
The effect of gamma-aminobutyric acid on 3H-flunitrazepam binding in rat brain.
European journal of pharmacology 1978;50(4):445-7.
1978: Roeske W R; Yamamura H I
Maturation of mammalian myocardial muscarinic cholinergic receptors.
Life sciences 1978;23(2):127-32.
1978: Hruska R E; White R; Azari J; Yamamura H I
Muscarinic cholinergic receptors in mammalian retina.
Brain research 1978;148(2):493-8.
1978: Beaumont K; Chilton W S; Yamamura H I; Enna S J
Muscimol binding in rat brain: association with synaptic GABA receptors.
Brain research 1978;148(1):153-62.
1978: Fields J Z; Roeske W R; Morkin E; Yamamura H I
Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization.
The Journal of biological chemistry 1978;253(9):3251-8.
1978: Speth R C; Wastek G J; Johnson P C; Yamamura H I
Benzodiazepine binding in human brain: characterization using [3H]flunitrazepam.
Life sciences 1978;22(10):859-66.
1978: Hruska R E; Padjen A; Bressler R; Yamamura H I
Taurine: sodium-dependent, high-affinity transport into rat brain synaptosomes.
Molecular pharmacology 1978;14(1):77-85.
1978: Reisine T D; Fields J Z; Bird E D; Spokes E; Yamamura H I
Characterization of brain dopaminergic receptors in Huntington's disease.
Communications in psychopharmacology 1978;2(2):79-84.
1977: Fields J Z; Reisine T D; Yamamura H I
Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol.
Brain research 1977;136(3):578-84.
1977: Enna S J; Stern L Z; Wastek G J; Yamamura H I
Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.
Archives of neurology 1977;34(11):683-5.
1977: Arregui A; Bennett J P; Bird E D; Yamamura H I; Iversen L L; Snyder S H
Huntington's chorea: selective depletion of activity of angiotensin coverting enzyme in the corpus striatum.
Annals of neurology 1977;2(4):294-8.
1977: Reisine T D; Fields J Z; Stern L Z; Johnson P C; Bird E D; Yamamura H I
Alterations in dopaminergic receptors in Huntington's disease.
Life sciences 1977;21(8):1123-8.
1977: Harris L W; Kundig F; Yamamura H I
Partial purification and separation of retinal acetylcholinesterase from butyrylcholinesterase by affinity chromatography.
Biochemical pharmacology 1977;26(15):1441-3.
1977: Speth R C; Chen F M; Lindstrom J M; Kobayashi R M; Yamamura H I
Nicotinic cholinergic receptors in rat brain identified by [125I]Naja naja siamensis alpha-toxin binding.
Brain research 1977;131(2):350-5.
1977: Reisine T D; Fields J Z; Yamamura H I
Neurotransmitter receptor alterations in Parkinson's disease.
Life sciences 1977;21(3):335-43.
1977: Wastek G J; Stern L Z; Yamamura H I
Recent advances in the neurochemistry of Huntington's disease.
Arizona medicine 1977;34(8):547-8.
1977: Hruska R E; Huxtable R J; Yamamura H I
Purification of [3H]taurine of high specific activity.
Analytical biochemistry 1977;79(1-2):568-70.
1977: Yaksh T L; Yamamura H I
Depression by morphine of the resting and evoked release of [3H]-acetylcholine from the cat caudate nucleus in vivo.
Neuropharmacology 1977;16(4):227-33.
1977: Snyder S H; Yamamura H I
Antidepressants and the muscarinic acetylcholine receptor.
Archives of general psychiatry 1977;34(2):236-9.
1977: Enna S J; Bennett J P; Bylund D B; Creese I; Burt D R; Charness M E; Yamamura H I; Simantov R; Snyder S H
Neurotransmitter receptor binding: regional distribution in human brain.
Journal of neurochemistry 1977;28(1):233-6.
1976: Coyle J T; Yamamura H I
Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain.
Brain research 1976;118(3):429-40.
1976: Wastek G J; Stern L Z; Johnson P C; Yamamura H I
Huntington's disease: regional alteration in muscarinic cholinergic receptor binding in human brain.
Life sciences 1976;19(7):1033-9.
1976: Adams G K; Yamamura H I; O'Leary J F
Recovery of central respiratory function following anticholinesterase intoxication.
European journal of pharmacology 1976;38(1):101-12.
1976: Kuhar M; Yamamura H I
Localization of cholinergic muscarinic receptors in rat brain by light microscopic radioautography.
Brain research 1976;110(2):229-43.
1976: Enna S J; Bird E D; Bennett J P; Bylund D B; Yamamura H I; Iversen L L; Snyder S H
Huntington's chorea. Changes in neurotransmitter receptors in the brain.
The New England journal of medicine 1976;294(24):1305-9.
1976: Yamamura H I; Manian A A; Snyder S H
Muscarinic cholinergic receptor binding: influence of pimozide and chlorpromazine metabolites.
Life sciences 1976;18(7):685-91.
1976: Enna S J; Yamamura H I; Snyder S H
Development of muscarinic cholinergic and GABA receptor binding in chick embryo brain.
Brain research 1976;101(1):177-83.
1976: Jones B C; Beaumont K; Hruska R E; Wastek G J; Yamamura H I
L-histidine: high affinity transport into rat brain synaptosomes.
Proceedings of the Western Pharmacology Society 1976;19():157-9.
1976: Hruska R E; Huxtable R J; Bressler R; Yamamura H I
Sodium-dependent high affinity transport of taurine into rat brain synaptosomes.
Proceedings of the Western Pharmacology Society 1976;19():152-6.
1976: Yamamura H I; Wastek G; Chang K J; Snyder S H
Cholinergic receptors in the mammalian central nervous system.
Proceedings of the Western Pharmacology Society 1976;19():13-8.
1976: Wastek G J; Johnson P C; Stern L Z; Yamamura H I
Alterations in brain muscarinic cholinergic receptor binding and choline acetyltransferase activity in Huntington's disease.
Proceedings of the Western Pharmacology Society 1976;19():170-1.
1975: Yaksh T L; Filbert M G; Harris L W; Yamamura H I
Acetylcholinesterase turnover in brain, cerebrospinal fluid and plasma.
Journal of neurochemistry 1975;25(6):853-60.
1975: Kuhar M J; DeHaven R N; Yamamura H I; Rommel-Spacher H; Simon J R
Further evidence for cholinergic habenulo-interpeduncular neurons: pharmacologic and functional characteristics.
Brain research 1975;97(2):265-75.
1975: Snyder S H; Chang K J; Kuhar M J; Yamamura H I
Biochemical indentification of the mammalian muscarinic cholinergic receptor.
Federation proceedings 1975;34(10):1915-21.
1975: Yaksh T L; Yamamura H I
The release in vivo of [3-H] acetylcholine from cat caudate nucleus and cerebral cortex by atropine, pentylenetetrazol, K-+ -depolarization and electrical stimulation.
Journal of neurochemistry 1975;25(2):123-30.
1975: Guarnieri M; Krell L S; McKhann G M; Pasternak G W; Yamamura H I
The effects of cell isolation techniques on neuronal membrane receptors.
Brain research 1975;93(2):337-42.
1975: Kuhar M J; Yamamura H I
Light autoradiographic localisation of cholinergic muscarinic receptors in rat brain by specific binding of a potent antagonist.
Nature 1975;253(5492):560-1.
1975: Yaksh T L; Yamamura H I
Blockade by morphine of acetylcholine release from the caudate nucleus in the mid-pontine pretrigeminal cat.
Brain research 1975;83(3):520-4.
1974: Lanks K; Somers L; Papirmeister B; Yamamura H
Choline transport by neuroblastoma cells in tissue culture.
Nature 1974;252(5483):476-8.
1974: Yamamura H I; Kuhar M J; Snyder S H
In vivo identification of muscarinic cholinergic receptor binding in rat brain.
Brain research 1974;80(1):170-6.
1974: Yamamura H I; Snyder S H
Postsynaptic localization of muscarinic cholinergic receptor binding in rat hippocampus.
Brain research 1974;78(2):320-6.
1974: Yaksh T L; Yamamura H I
Factors affecting performance of the push-pull cannula in brain.
Journal of applied physiology 1974;37(3):428-34.
1974: Snyder S; Greenberg D; Yamamura H I
Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.
Archives of general psychiatry 1974;31(1):58-61.
1974: Yamamura H I; Snyder S H
Muscarinic cholinergic binding in rat brain.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(5):1725-9.
1974: Mulder A H; Yamamura H I; Kuhar M J; Snyder S H
Release of acetylcholine from hippocampal slices by potassium depolarization: dependence on high affinity choline uptake.
Brain research 1974;70(2):372-6.
1974: Yaksh T L; Yamamura H I; Fedele L A
Appearance in cat cerebrospinal fluid of radiolabelled metabolites following intraventricular injection of (3H)choline.
The Journal of pharmacy and pharmacology 1974;26(1):65-7.
1973: Yamamura H I; Snyder S H
High affinity transport of choline into synaptosomes of rat brain.
Journal of neurochemistry 1973;21(6):1355-74.
1973: Yamamura H I; Reichard D W; Gardner T L; Morrisett J D; Broomfield C A
Guinea pig brain acetylcholinesterase: partial purification by affinity chromatography.
Biochimica et biophysica acta 1973;302(2):305-15.
1973: Yaksh T L; Fedele L A; Yamamura H I
Effects of repeated withdrawal of cerebrospinal fluid by cisternal puncture on cisternal protein levels in the unanesthetized cat.
Physiology & behavior 1973;10(1):149-51.
1972: Adams G K; Yamamura H I; O'Leary J F
Spontaneous recovery of central respiratory function after an irreversible AChE inhibitor.
European journal of pharmacology 1972;20(3):377-80.
1972: Yamamura H I; Snyder S H
Choline: high-affinity uptake by rat brain synaptosomes.
Science (New York, N.Y.) 1972;178(61):626-8.
1971: Harris L W; Yamamura H I; Fleisher J H
De novo synthesis of acetylcholinesterase in guinea pig retina after inhibition by pinacolyl methylphosphonofluoridate.
Biochemical pharmacology 1971;20(10):2927-30.
1971: Harris L W; Fleisher J H; Yamamura H I
Effects of 2-PAMC1 and toxogonin on retinal and brain acetylcholinesterase inhibited by sarin.
European journal of pharmacology 1971;14(1):38-46.
1969: Yamamura H I; Horita A
A further study of the effect of propranolol on the blockade of alpha adrenergic receptors.
European journal of pharmacology 1969;7(3):258-63.
1968: Yamamura H I; Horita A
Effect of propranolol on the blockade of alpha adrenergic receptors.
The Journal of pharmacology and experimental therapeutics 1968;164(1):82-9.
1968: Lee I P; Yamamura H I; Dixon R L
The effects of beta-diethylaminoethyl-diphenylpropylacetate (SKE 525-A) on biological membranes. I. SKF 525-A-induced stabilization of human erythrocytes.
Biochemical pharmacology 1968;17(8):1671-81.
1968: Yamamura H I; Lee I P; Dixon R L
Study of the sympathomimetic action of cyclohexylamine, a possible metabolite of cyclamate.
Journal of pharmaceutical sciences 1968;57(7):1132-4.
1968: Yamamura H I; Horita A
A further study of the antagonistic action between alpha and beta blocking agents.
Proceedings of the Western Pharmacology Society 1968;11():73-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Henry Yamamura

Research Profile (preview)

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Henry Yamamura (preview)

All Publications